<SEC-DOCUMENT>0001048477-26-000002.txt : 20260223
<SEC-HEADER>0001048477-26-000002.hdr.sgml : 20260223
<ACCEPTANCE-DATETIME>20260223160842
ACCESSION NUMBER:		0001048477-26-000002
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20260223
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260223
DATE AS OF CHANGE:		20260223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMARIN PHARMACEUTICAL INC
		CENTRAL INDEX KEY:			0001048477
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				680397820
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26727
		FILM NUMBER:		26665194

	BUSINESS ADDRESS:	
		STREET 1:		105 DIGITAL DRIVE
		CITY:			NOVATO
		STATE:			CA
		ZIP:			94949
		BUSINESS PHONE:		4155066700

	MAIL ADDRESS:	
		STREET 1:		105 DIGITAL DRIVE
		CITY:			NOVATO
		STATE:			CA
		ZIP:			94949
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bmrn-20260223.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:d4c8c5e5-e3b8-46bb-958c-45342599d360,g:ac1fd622-f461-4f44-90c4-0035f5e63a78,d:35ddb55885d345cfa3b42a51b9beaa5c-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bmrn-20260223</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001048477</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bmrn-20260223.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001048477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-02-23</xbrli:startDate><xbrli:endDate>2026-02-23</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i35ddb55885d345cfa3b42a51b9beaa5c_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:174%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:144%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-top:11pt;padding-left:108pt;padding-right:108pt;text-align:center"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">February&#160;23, 2026</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">BioMarin Pharmaceutical Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-26727</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">68-0397820</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">770 Lindaro Street</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">San Rafael</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">California</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">94901</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices)</span></div></td><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Zip Code)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">415</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">506-6700</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:110%">(Registrant's telephone number, including area code)</span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Not Applicable </span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric> </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric> </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"/><td style="width:30.074%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.032%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.390%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.001</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">BMRN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i35ddb55885d345cfa3b42a51b9beaa5c_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February&#160;23, 2026, BioMarin Pharmaceutical Inc. (the Company) announced financial results for its fourth quarter ended December&#160;31, 2025. The Company&#8217;s press release issued on February&#160;23, 2026 is attached hereto as Exhibit 99.1 and is incorporated by reference herein.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information in this Form 8-K, including in the press release furnished as Exhibit 99.1 hereto, shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities under that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the Securities Act), nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i35ddb55885d345cfa3b42a51b9beaa5c_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"/><td style="width:14.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:82.981%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="earningsrelease-23feb26ex9.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Press Release of the Company dated February&#160;23, 2026</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i35ddb55885d345cfa3b42a51b9beaa5c_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"/><td style="width:47.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.112%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BioMarin Pharmaceutical Inc., <br/>a Delaware corporation</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date: February&#160;23, 2026</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ G. Eric Davis</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">G. Eric Davis</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Executive Vice President, Chief Legal Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>earningsrelease-23feb26ex9.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i07d055eb4bef4672b5339774bb16e563_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><img alt="image.jpg" src="image.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:48.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Contact&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Investors&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Media&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Traci McCarty</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Marni Kottle</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BioMarin Pharmaceutical Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">BioMarin Pharmaceutical Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(415) 455-7558</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(650) 374-2803</font></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Full-year 2025 Total Revenues Increased 13% Y&#47;Y to $3.2 Billion, Led by 9% Revenue Growth for Enzyme Therapies and 26% Revenue Growth for VOXZOGO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fourth Quarter 2025 Total Revenues Increased 17% Y&#47;Y Led by 13% Revenue Growth for Enzyme Therapies and 31% Revenue Growth for VOXZOGO</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Announced Definitive Agreement to Acquire Amicus Therapeutics, including Galafold</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for Fabry Disease and Pombiliti</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> + Opfolda</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for Pompe Disease&#59; Expected to Significantly Accelerate and Diversify Revenues </font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioMarin Provides 2026 Guidance Excluding any Post-Close Contribution from the Announced Acquisition of Amicus, Anticipated to Close in Q2&#8217;26</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Conference Call and Webcast Scheduled Today at 4&#58;30 p.m. ET</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SAN RAFAEL, Calif., February&#160;23, 2026 &#8211; BioMarin Pharmaceutical Inc. (NASDAQ&#58; BMRN) today announced financial results for the fourth quarter and full year ended December&#160;31, 2025. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;In 2025, operational excellence led to strengthening financial results, including double-digit topline growth, strong profitability and increasing cash flow. We also advanced multiple medicines in our pipeline and closed the year by announcing the acquisition of Amicus,&#8221; said Alexander Hardy, President and Chief Executive Officer of BioMarin. &#8220;The Amicus transaction, which is expected to close in the second quarter, represents a compelling opportunity to reach more patients around the world and further strengthen our revenue growth through the next decade.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;We expect to build on this success in 2026, with another year of strong financial performance and momentum across the business. We look forward to adding Galafold and Pombiliti + Opfolda to our growing commercial enzyme therapies business, and to continued strong growth from VOXZOGO. Beyond our current commercial portfolio, we are excited by the progress we are seeing across our R&#38;D pipeline and look forward to a multitude of pipeline catalysts throughout the year. These include three major data read-outs to support regulatory approvals, two age label expansions, plus the advancement of multiple clinical programs position us for significant portfolio progress. We are energized by what lies ahead this year and intend to deliver again on an ambitious set of priorities, demonstrating our dedication to innovation and sustained growth in ways that we believe will benefit patients, employees, and shareholders.&#8221;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">2025 Business Highlights</font></div><div style="margin-bottom:10pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Innovation</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Accelerated development of BMN 333, BioMarin&#8217;s long-acting C-type natriuretic peptide (CNP), with Phase 1 PK data exceeding targeted free CNP exposure levels, reflecting its potential to become the new standard of care in achondroplasia.</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Advanced five new VOXZOGO indications within the CANOPY program, including a pivotal Phase 3 study in hypochondroplasia and Phase 2 studies in idiopathic short stature, Noonan syndrome, Turner syndrome, and SHOX deficiency.</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Reported positive data from the PALYNZIQ</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Phase 3 PEGASUS study in 12- to 17-year-olds demonstrating statistically significant reductions in blood phenylalanine (Phe) compared to diet alone for adolescents with PKU.</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Progressed BMN 351 for Duchenne muscular dystrophy, with initial Phase 1&#47;2 data demonstrating 5.0% mean absolute dystrophin expression (without double-correction for histologic adjustment for muscle content) at week 25 in the 9 mg&#47;kg cohort. The 12 mg&#47;kg dose cohort continues to enroll participants, with topline data readout from this cohort expected in 2H&#8217;26.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Growth</font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Strong patient demand across the portfolio fueled 13% Y&#47;Y full-year 2025 total revenue growth.</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Enzyme Therapies full-year 2025 revenue advanced 9% Y&#47;Y, supported by sustained high market penetration and patient adherence, led by robust 22% Y&#47;Y growth from PALYNZIQ.</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">VOXZOGO generated 26% Y&#47;Y revenue growth for full-year 2025, driven by deeper market penetration and increasing demand for the treatment of achondroplasia across 55 commercial markets. Markets outside of the U.S. (OUS) drove approximately 73% of VOXZOGO revenue in full-year 2025, reflecting the therapy&#8217;s strong uptake across global markets.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Value Commitment</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Announced the acquisition of Amicus Therapeutics in December 2025, expected to close in Q2&#8217;26, subject to regulatory clearances, approval by the stockholders of Amicus and other customary closing conditions.  The addition of high-growth products, Galafold for Fabry Disease and Pombiliti + Opfolda for Pompe Disease, is expected to accelerate BioMarin&#8217;s revenue growth and increase profitability. Adolescent label expansion for Pombiliti + Opfolda is anticipated in 2H&#8217;26.</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Generated operating cash flows totaling $100 million in fourth quarter 2025 and $828 million for the full year. Total cash and investments totaled approximately $2 billion at year-end, and continued increasing operating cash flow is expected to support sustained investment in innovation and future growth.</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Strong performance in 2025 led to significant GAAP and Non-GAAP Diluted Earnings per Share expansion, excluding acquired in-process research and development (IPR&#38;D) charges related to the acquisition of Inozyme, $1.10 per share, and an inventory write-off related to ROCTAVIAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, totaling $0.46 per share after tax. </font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">The company secured financing of approximately $3.7 billion of non-convertible debt to support the Amicus acquisition with strong demand, achieving favorable pricing across the capital structure.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Anticipated 2026 Program Updates</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">VOXZOGO&#58;</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Phase 3 hypochondroplasia data 1H&#8217;26&#59; regulatory submissions 2H&#8217;26</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">U.S. supplemental new drug application (sNDA) for full approval of VOXZOGO in achondroplasia Q2&#8217;26</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Advancing Phase 2 studies in idiopathic short stature, Noonan syndrome, Turner syndrome, SHOX deficiency</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">BMN 333 (long-acting CNP)&#58;</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Initiate registration-enabling Phase 2&#47;3 study in achondroplasia 1H&#8217;26</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PALYNZIQ&#58;</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">U.S. PDUFA date for the adolescent label expansion February 28, 2026&#59; EU approval 2026</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">BMN 401&#58;</font></div><div><font><br></font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Phase 3 topline data in 1 to 12 year-old population with ENPP1 deficiency 1H&#8217;26&#59; global regulatory submissions 2H&#8217;26&#59; potential first&#8209;in&#8209;disease launch 2027</font></div><div style="text-indent:9pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">BMN 351</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Phase 1&#47;2 data presentation for 6 mg&#47;kg and 9 mg&#47;kg cohorts at Muscular Dystrophy Association (MDA) Clinical &#38; Scientific Congress (March 8&#8211;11, 2026)</font></div><div style="text-indent:9pt"><font><br></font></div><div style="text-indent:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ROCTAVIAN</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.5pt">Following the company&#8217;s October announcement to explore options to divest ROCTAVIAN, BioMarin undertook a comprehensive effort to identify a potential buyer. Despite these efforts, BioMarin was unable to identify a qualified buyer and has made the decision to voluntarily withdraw ROCTAVIAN from the market. </font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Fourth Quarter 2025 Financial Highlights</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.5pt">Total Revenues </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for the fourth quarter of 2025 were $875 million, an increase of 17% compared to the same period in 2024, driven by 31% year-over-year VOXZOGO revenue growth from new patients initiating therapy across all regions and the timing of large government orders, primarily in Latin America. In the quarter, revenues from BioMarin&#8217;s Enzyme Therapies (ALDURAZYME</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, BRINEURA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, NAGLAZYME</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, PALYNZIQ and VIMIZIM</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) also increased by 13% compared to the fourth quarter of 2024, driven by a combination of increased patient demand in all regions and the timing of large government orders. </font></div><div><font><br></font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.5pt">GAAP Net Loss</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> was $47 million for the fourth quarter of 2025 compared to GAAP Net Income of $125 million for the same period in 2024. The increase in GAAP Net Loss was primarily due to the company&#8217;s strategic decision to voluntarily withdraw ROCTAVIAN from the market resulting in charges of approximately $240 million during the quarter. These charges were mainly comprised of $119 million of an inventory write-off that was included in Cost of Sales and $118 million of long-lived asset impairments included in Selling, General and Administrative expense. The increase in GAAP Net Loss was partially offset by improved revenue growth as mentioned above and lower provision for income taxes.  </font></div><div><font><br></font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:5.5pt">Non-GAAP Income </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for the fourth quarter of 2025 decreased to $89 million compared to $180 million for the same period in 2024. The decrease in Non-GAAP Income was primarily due to the ROCTAVIAN inventory write- off included in Cost of Sales. The decrease in Non-GAAP Income was partially offset by improved revenue growth as mentioned above.  </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br>December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Revenues</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$875</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$747</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3,221</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$2,854</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Product Revenues by Product&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">VOXZOGO</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$273</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$208</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$927</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$735</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Enzyme Therapies&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VIMIZIM</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$206</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$191</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$792</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$740</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NAGLAZYME</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">485</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PALYNZIQ</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">433</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ALDURAZYME</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BRINEURA</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Enzyme Therapies Revenue</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$549</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$488</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,105</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1,928</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">KUVAN</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$23</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$28</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$100</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$121</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROCTAVIAN</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$13</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$36</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$26</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GAAP Net Income (Loss) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$(47)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(138)%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$349</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$427</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-GAAP Income </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$89</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$180</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$614</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$686</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GAAP Operating Margin % </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(3)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.1)%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.6%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-GAAP Operating Margin % </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)(5)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.1%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.3%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.6%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GAAP Diluted Earnings (Loss) per Share (EPS)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(4)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$(0.24)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.64</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(138)%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.80</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2.21</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-GAAP Diluted EPS </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)(5)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.46</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.92</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3.15</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3.52</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)%</font></td></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(1)&#160;&#160;&#160;&#160;Includes acquired IPR&#38;D charges of $221 million (or approximately $1.10 on a per share basis) related to acquisition of Inozyme for the twelve months ended December 31, 2025. </font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">(2) &#160;&#160;&#160;&#160;Refer to Non-GAAP Information beginning on page </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="#i07d055eb4bef4672b5339774bb16e563_13" style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline">10</a></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> of this press release for definitions of Non-GAAP Income, Non-GAAP Operating Margin percentage and Non-GAAP Diluted EPS along with the related reconciliations to the comparable information reported under U.S. GAAP.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) &#160;&#160;&#160;&#160;GAAP Operating Margin percentage is defined by the company as GAAP Income (Loss) from Operations divided by Total Revenues.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Includes approximately $240 million of restructuring charges (or approximately $0.94 after tax on a per share basis) related to the company&#8217;s strategic decision to voluntarily withdraw ROCTAVIAN from the market for the three and twelve months ended December 31, 2025.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;Includes $119 million inventory write-off (or approximately $0.46 after tax on a per share basis) related to the company&#8217;s strategic decision to voluntarily withdraw ROCTAVIAN from the market for the three and twelve months ended December 31, 2025.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Forward-Looking Non-GAAP Financial Information </font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioMarin does not provide guidance for GAAP reported financial measures (other than revenue) or a reconciliation of forward-looking Non-GAAP financial measures to the most directly comparable GAAP reported financial measures because the company is unable to predict with reasonable certainty the financial impact of changes resulting from its strategic portfolio and business operating model reviews&#59; potential future asset impairments&#59; gains and losses on investments&#59; and other unusual gains and losses without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period. As such, any reconciliations provided would imply a degree of precision that could be confusing or misleading to investors.</font></div><div style="margin-top:10pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2026 Full-Year Financial Guidance (in millions, except EPS amounts)</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">2026 guidance excludes any post-close contribution from the announced acquisition of Amicus Therapeutics, anticipated to close in Q2&#8217;26</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Total Revenues guidance reflects expectation of continued strong patient demand across Enzyme Therapies and VOXZOGO in 2026</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Other Revenue guidance reflects KUVAN, royalty revenue (including conclusion of U.S. Firdapse royalty term in January 2026), and the company&#8217;s strategic decision to voluntarily withdraw ROCTAVIAN from the market</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Non-GAAP Diluted EPS guidance includes approximately $0.25 of pre-close operating and interest expenses associated with the Amicus transaction</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">In 2026, excluding the impact of the Amicus transaction, Non-GAAP Operating Margin is expected to be approximately 40% for the full year</font></div><div style="margin-bottom:12pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.308%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.529%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Item</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025 Actuals</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2026 Guidance</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3,221</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3,325</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3,425</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Enzyme Therapies</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,105</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,225</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,275</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VOXZOGO</font></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$927</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$975</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1,025</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Revenues</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$189</font></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$100</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-GAAP Diluted EPS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)(3)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3.15</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4.95</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5.15</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Other Revenues includes KUVAN, ROCTAVIAN, and royalties</font></div><div style="margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)  Refer to Non-GAAP Information beginning on page </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i07d055eb4bef4672b5339774bb16e563_13" style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">10</a></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of this press release for definition of Non-GAAP Diluted EPS. </font></div><div style="margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Non-GAAP Diluted EPS guidance assumes approximately 200 million Weighted-Average Diluted Shares Outstanding.</font></div><div style="margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:4pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioMarin will host a conference call and webcast to discuss fourth quarter 2025 financial results today, Monday, February&#160;23, 2026, at 4&#58;30 p.m. ET. This event can be accessed through this link or on the investor section of the BioMarin website at&#160;www.biomarin.com.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.701%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.&#47;Canada Dial-in Number&#58; 800-715-9871</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Replay Dial-in Number&#58; 800-770-2030</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Dial-in Number&#58;  646-307-1963</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Replay International Dial-in Number&#58; 609-800-9909</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Conference ID&#58;  4503000&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conference ID&#58; 4503000&#160;</font></div></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About BioMarin</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the&#8239;San Rafael, California-based company has a proven track record of innovation, with multiple commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit www.biomarin.com.</font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This press release and the associated conference call and webcast contain forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc. (BioMarin), including, without limitation, statements about&#58; future financial performance, including the expectations of Total Revenues, Non-GAAP Operating Margin percentage, and Non-GAAP Diluted EPS for the full-year 2026 and future periods, and the underlying drivers of those results, such as the expected demand and continued growth of BioMarin&#8217;s Enzyme Therapies portfolio, the expected growth from VOXZOGO, and the expected impact of Other Revenues&#59; the anticipated closing and benefits of BioMarin&#8217;s proposed acquisition of Amicus Therapeutics, Inc.&#59; BioMarin&#8217;s plans for investment in innovation and future growth&#59; the timing of orders for commercial products&#59; plans and expectations regarding the development, commercialization and commercial prospects of BioMarin&#8217;s product candidates and commercial products, including the prospects and timing of actions relating to clinical studies and trials and product approvals, such as study initiations, study advancements, data readouts, submissions, filings, approvals, and label expansions&#59; the expected benefits and availability of BioMarin&#8217;s commercial products and product candidates&#59; and potential growth opportunities and trends, including the assumptions and expectations regarding total addressable patient population (TAPP) with respect to the conditions targeted by BioMarin&#8217;s product candidates and commercial products. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others&#58; BioMarin&#8217;s success in the commercialization of its commercial products&#59; BioMarin&#8217;s ability to consummate and realize the anticipated benefits of any acquisitions&#59; impacts of macroeconomic and other external factors on BioMarin&#8217;s operations, regulatory uncertainty, the impact of new or increased tariffs, other trade protection measures, and escalating trade tensions&#59; results and timing of current and planned preclinical studies and clinical trials and the release of data from those trials&#59; BioMarin&#8217;s ability to successfully manufacture its commercial products and product candidates&#59; the content and timing of decisions by the U.S. Food and Drug Administration, the European Medicines Agency, the European Commission and other regulatory authorities concerning each of the described products and product candidates&#59; the market for each of these products&#59; BioMarin&#8217;s ability to meet product demand&#59; actual sales of BioMarin&#8217;s commercial products&#59; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption &#8220;Risk Factors&#8221; in BioMarin's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, as such factors may be updated by any subsequent reports. Investors are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioMarin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, VOXZOGO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, VIMIZIM</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NAGLAZYME</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, PALYNZIQ</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, BRINEURA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, KUVAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ROCTAVIAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are registered trademarks of BioMarin Pharmaceutical Inc., or its affiliates. ALDURAZYME</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a registered trademark of BioMarin&#47;Genzyme LLC. All other brand names and service marks, trademarks and other trade names appearing in this release are the property of their respective owners.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><div id="i07d055eb4bef4672b5339774bb16e563_4"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three and Twelve Months Ended December 31, 2025 and 2024</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. dollars, except per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited)</font></div><div style="margin-bottom:20pt;text-align:center"><font><br></font></div><div style="margin-bottom:20pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.448%"><tr><td style="width:1.0%"></td><td style="width:43.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.072%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.077%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Twelve Months Ended<br>December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">REVENUES&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net product revenues</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">859,321&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">735,634&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,167,759&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,809,445&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalty and other revenues</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,244&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,679&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53,494&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,470&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">874,565&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">747,313&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,221,253&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,853,915&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OPERATING EXPENSES&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of sales </font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,709&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,139&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">717,442&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">580,235&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192,413&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173,509&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">921,930&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">747,184&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling, general and administrative</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">446,207&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266,607&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,153,017&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,009,025&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible asset amortization</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,846&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,651&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,386&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,257&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of nonfinancial assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,000)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">919,175&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">585,906&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,811,775&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,369,701&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INCOME (LOSS) FROM OPERATIONS</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44,610)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">161,407&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409,478&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">484,214&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,210&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,680&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,904&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,883&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,778)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,577)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,899)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,666)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,025&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,871)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,997&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,668)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INCOME (LOSS) BEFORE INCOME TAXES</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,153)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169,639&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">482,480&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">541,763&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,420&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,696&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133,579&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114,904&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NET INCOME (LOSS)</font></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(46,573)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124,943&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348,901&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">426,859&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EARNINGS (LOSS) PER SHARE, BASIC</font></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.24)</font></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.66&#160;</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.82&#160;</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.25&#160;</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EARNINGS (LOSS) PER SHARE, DILUTED</font></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.24)</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.64&#160;</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.80&#160;</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.21&#160;</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, basic</font></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192,225&#160;</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190,688&#160;</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191,787&#160;</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190,027&#160;</font></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, diluted</font></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192,225&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,581&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197,394&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,708&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><div id="i07d055eb4bef4672b5339774bb16e563_7"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December&#160;31, 2025 and 2024 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In thousands of U.S. dollars, except per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:63.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.344%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,311,679&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">942,842&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248,930&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">194,864&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">908,214&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">660,535&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,298,883&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232,653&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">185,784&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,533&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,953,490&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,232,427&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent assets&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term investments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">492,242&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">521,238&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant and equipment, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">952,508&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,043,041&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">213,837&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255,278&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,199&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,199&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,508,697&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,489,366&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">277,049&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251,391&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,594,022&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,988,940&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">759,031&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">606,988&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">759,031&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">606,988&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncurrent liabilities&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term convertible debt, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">597,176&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">595,138&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150,816&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128,824&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,507,023&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,330,950&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:14.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $0.001 par value&#58; 500,000,000 shares authorized&#59; 192,300,091 and 190,761,349 shares issued and outstanding, respectively</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,956,582&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,802,068&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company common stock held by the Nonqualified Deferred Compensation Plan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,508)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,227)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,473)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,653&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings (accumulated deficit)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154,206&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(194,695)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,086,999&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,657,990&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,594,022&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,988,940&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><div id="i07d055eb4bef4672b5339774bb16e563_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BIOMARIN PHARMACEUTICAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Twelve Months Ended December 31, 2025 and 2024 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands of U.S. dollars)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.235%"><tr><td style="width:1.0%"></td><td style="width:66.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.308%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348,901&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">426,859&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79,557&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96,426&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash interest expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,622&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,359&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accretion of discount on investments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,801)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,345)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181,409&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,571&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of nonfinancial assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,000)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,012&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,889&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ROCTAVIAN inventory write-off</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119,208&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,738&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,096&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized foreign exchange gain</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,459&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16,753)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired in-process research &#38; development expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220,963&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,414)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,135&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(228,054)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(57,909)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(116,929)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(63,530)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,891&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,778)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38,573)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(73,700)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,136&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32,240)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,869&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,761&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">827,994&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">572,841&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(103,038)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(85,424)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maturities and sales of investments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">337,801&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">633,018&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(355,875)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(410,250)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of nonfinancial assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of intangible assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,937)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,994)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition, net of cash acquired</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(285,193)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,141&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(414,242)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,491&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercises of awards under equity incentive plans</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,460&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,277&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(55,965)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(77,560)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayments of convertible debt</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(494,987)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(889)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,177)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</font></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42,394)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(526,447)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,521)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,830&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">368,837&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187,715&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning of period</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">942,842&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">755,127&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">End of period</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,311,679&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">942,842&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><div id="i07d055eb4bef4672b5339774bb16e563_13"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Information</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results presented in this press release include both GAAP information and Non-GAAP information. Non-GAAP Income is defined by the company as GAAP Net Income (Loss) excluding amortization of intangible assets, stock-based compensation expense and, in certain periods, certain other specified items, as detailed below when applicable. The company also includes a Non-GAAP adjustment for the estimated tax impact of the reconciling items. Non-GAAP R&#38;D expenses and Non-GAAP SG&#38;A expenses are defined by the company as GAAP R&#38;D expenses and GAAP SG&#38;A expenses, respectively, excluding stock-based compensation expense and, in certain periods, certain other specified items, as detailed below when applicable. Non-GAAP Operating Margin </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">percentage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is defined by the company as GAAP Income (Loss) from Operations, excluding amortization of intangible assets, stock-based compensation expense and, in certain periods, certain other specified items, divided by GAAP Total Revenues. Non-GAAP Diluted EPS is defined by the company as Non-GAAP Income divided by Non-GAAP Weighted-Average Diluted Shares Outstanding. Non-GAAP Weighted-Average Diluted Shares Outstanding is defined by the company as GAAP Weighted-Average Diluted Shares Outstanding, adjusted to include any common shares issuable under the company&#8217;s equity plans or convertible debt in periods when they are dilutive under Non-GAAP. </font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioMarin regularly uses both GAAP and Non-GAAP results and expectations internally to assess its financial operating performance and evaluate key business decisions related to its principal business activities&#58; the discovery, development, manufacture, marketing and sale of innovative biologic therapies. BioMarin also uses Non-GAAP Income internally to understand, manage and evaluate its business and to make operating decisions, and compensation of executives is based in part on this measure. Because these Non-GAAP metrics are important internal measurements for BioMarin, the company believes that providing this information in conjunction with BioMarin&#8217;s GAAP information enhances investors&#8217; and analysts&#8217; ability to meaningfully compare the company&#8217;s results from period to period and to its forward-looking guidance, and to identify operating trends in the company&#8217;s principal business. </font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for, or superior to comparable GAAP measures and should be read in conjunction with the consolidated financial information prepared in accordance with GAAP. Investors should note that the Non-GAAP information is not prepared under any comprehensive set of accounting rules or principles and does not reflect all of the amounts associated with the company&#8217;s results of operations as determined in accordance with GAAP. Investors should also note that these Non-GAAP financial measures have no standardized meaning prescribed by GAAP and, therefore, have limits in their usefulness to investors. In addition, from time to time in the future there may be other items that the company may exclude for purposes of its Non-GAAP financial measures&#59; likewise, the company may in the future cease to exclude items that it has historically excluded for purposes of its Non-GAAP financial measures. Because of the non-standardized definitions, the Non-GAAP financial measure as used by BioMarin in this press release and the accompanying tables may be calculated differently from, and therefore may not be directly comparable to, similarly titled measures used by other companies.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the reconciliation of GAAP reported to Non-GAAP adjusted financial information&#58;</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation of GAAP Reported Information to Non-GAAP Information </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(In millions of U.S. dollars, except per share data)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited) </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.258%"><tr><td style="width:1.0%"></td><td style="width:52.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Twelve Months Ended<br>December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP Reported Net Income (Loss)</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(47)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">125</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">349</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">427</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense - COS</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense - R&#38;D</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense - SG&#38;A</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition-related costs </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of nonfinancial assets </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Severance and restructuring costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (4)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on investments </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax effect of adjustments</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-GAAP Income</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">614&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">686&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.419%"><tr><td style="width:1.0%"></td><td style="width:20.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.097%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.251%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Twelve Months Ended<br>December 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">R&#38;D</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SG&#38;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">R&#38;D</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SG&#38;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">R&#38;D</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SG&#38;A</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">R&#38;D</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SG&#38;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP expenses</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">192</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">446</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">174</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">267</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">922</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,153</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">747</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,009</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(127)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition-related costs </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Severance and restructuring costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (4)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-GAAP expenses</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">867&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">901&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">688&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">786&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Twelve Months Ended<br>December 31,</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of GAAP Total Revenue</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of GAAP Total Revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of GAAP Total Revenue</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of GAAP Total Revenue</font></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP Income (Loss) from Operations</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(45)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">161</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">21.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">409</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">484</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17.0</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition-related costs </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of nonfinancial assets </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Severance and restructuring costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (4)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-GAAP Income from Operations</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">132&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.1&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.3&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">815&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.6&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:3pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center;text-indent:-27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:52.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Twelve Months Ended<br>December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP Diluted EPS</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.24)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.64</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.80</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.21</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.24&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.26&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.92&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.22&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition-related costs </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of nonfinancial assets </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.05)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Severance and restructuring costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (4)</font></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.63&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.05&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.63&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.49&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on investments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (5)</font></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax effect of adjustments</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.20)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.08)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.40)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.39)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-GAAP Diluted EPS</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.46&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.92&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.15&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.52&#160;</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Certain amounts may not sum or recalculate due to rounding.</font></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;These amounts were included in SG&#38;A and represent severance costs incurred in the acquisition of Inozyme in July 2025.</font></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents a payment triggered by a third party's attainment of a regulatory approval milestone related to previously sold intangible assets.</font></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;These amounts were included in SG&#38;A and represent impairment of long-lived assets, severance and other restructuring costs related to the company's 2025 strategic decision to voluntarily withdraw ROCTAVIAN from the market and 2024 corporate initiatives and the associated organizational redesign efforts.</font></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;Represents impairment loss on non-marketable equity securities recorded in Other income (expense), net.</font></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-27pt"><font><br></font></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.551%"><tr><td style="width:1.0%"></td><td style="width:56.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br>December 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Twelve Months Ended<br>December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP Weighted-Average Diluted Shares Outstanding</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">192.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">196.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">197.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">196.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the company's equity plans </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuable under the Company&#8217;s convertible debt</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-GAAP Weighted-Average Diluted Shares Outstanding</font></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197.4&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196.6&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197.4&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196.7&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Common stock issuable under the company&#8217;s equity plans and convertible debt were excluded from the computation of GAAP Weighted-Average Diluted Shares Outstanding for the three months ended December 31, 2025, as they were anti-dilutive.</font></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-27pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bmrn-20260223.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:d4c8c5e5-e3b8-46bb-958c-45342599d360,g:ac1fd622-f461-4f44-90c4-0035f5e63a78-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bmrn="http://www.biomarin.com/20260223" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.biomarin.com/20260223">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmrn-20260223_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmrn-20260223_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://www.biomarin.com/role/DocumentandEntityInformationDocument">
        <link:definition>0000001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>bmrn-20260223_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:d4c8c5e5-e3b8-46bb-958c-45342599d360,g:ac1fd622-f461-4f44-90c4-0035f5e63a78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7350a016-1368-43dd-b2e0-d9ce020e498d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_63aa3f30-2a7d-445d-84ff-77745e8b2a28_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b7b52acc-8b41-4a96-bfe2-57c0a3b922e9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_dfd42c9d-2742-4531-9268-8879d5f7d290_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_372f0ab2-7374-48ca-9773-7e7d87032194_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_d8307701-fa54-4ab8-a804-baaab5658662_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9a27d770-e074-4c5c-b949-0883a5608bb0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_20bb0d50-3bb2-4333-b8ce-460d7620f813_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_232e0f14-0cf7-4850-9599-8137b062abb2_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6534ead9-243e-4dd2-bf3e-99ee9f6221bc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e933d92e-69af-4fdf-a4c8-0ebfdebcb3c8_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_255b7d5f-4c6f-44ef-b025-b42a5d8c9b6b_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2dc50a29-4216-4450-8bd3-9493e0340ce2_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5f96e06e-4db7-4b8b-8a6b-eed6ea26ec44_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_3a2275c9-f333-4990-9c5c-d9fc1134e388_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_08214a98-55e4-4518-b50c-69ba17e16764_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7e176007-21c7-4f73-ba60-a9e0bea026be_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8a838e02-9154-4723-8440-ae3f421e9f60_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_dd678e77-7501-4fa1-ab35-2451a78a433a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_eff49955-b187-4394-9faa-7b2b66b2cb4f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_55a798b5-95db-4f0e-a8f1-cea1821a7efb_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a0f09b19-acc8-4c69-a672-79f023680472_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b0f7bf5c-d167-455a-abc4-185e0b8c3633_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>bmrn-20260223_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:d4c8c5e5-e3b8-46bb-958c-45342599d360,g:ac1fd622-f461-4f44-90c4-0035f5e63a78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.biomarin.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="bmrn-20260223.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://www.biomarin.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_bdc81120-8e2a-45e4-84a3-d2ab12d1da0f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_DocumentType_bdc81120-8e2a-45e4-84a3-d2ab12d1da0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5c3a9cbb-d2d2-4840-acb7-313dfe1bea94" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_DocumentPeriodEndDate_5c3a9cbb-d2d2-4840-acb7-313dfe1bea94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c2767aad-0ac9-4b8d-ac27-8516c2408fb6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_EntityRegistrantName_c2767aad-0ac9-4b8d-ac27-8516c2408fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3232ef82-d783-49f5-95b9-00563d70197f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3232ef82-d783-49f5-95b9-00563d70197f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_23b6c672-8602-42a3-a175-8ba372dd4e1c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_EntityFileNumber_23b6c672-8602-42a3-a175-8ba372dd4e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_22c1e32d-126f-47df-b23d-d721fed7dfef" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_EntityTaxIdentificationNumber_22c1e32d-126f-47df-b23d-d721fed7dfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f7cf3ebe-6340-472a-87c2-dd76ada45fc5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_EntityAddressAddressLine1_f7cf3ebe-6340-472a-87c2-dd76ada45fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_979a1767-90e4-4328-acaa-3d9e59719d18" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_EntityAddressCityOrTown_979a1767-90e4-4328-acaa-3d9e59719d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_053891d3-b398-44ce-a6f2-b81630f5a9cc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_EntityAddressStateOrProvince_053891d3-b398-44ce-a6f2-b81630f5a9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_da9eadb9-663e-4cbc-96b9-2d181df0adff" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_EntityAddressPostalZipCode_da9eadb9-663e-4cbc-96b9-2d181df0adff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a4b3c0b1-efaa-44c4-a6b4-1a5a51e30706" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_CityAreaCode_a4b3c0b1-efaa-44c4-a6b4-1a5a51e30706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3da18e1d-13ef-48d7-820e-5b80ceec55e9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_LocalPhoneNumber_3da18e1d-13ef-48d7-820e-5b80ceec55e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_fef34e0f-e637-4a12-b573-1319423c7e00" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_WrittenCommunications_fef34e0f-e637-4a12-b573-1319423c7e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_42e33513-8dd0-4b05-ab18-100f8edf62f9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_SolicitingMaterial_42e33513-8dd0-4b05-ab18-100f8edf62f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_45d4251d-ee9d-40e9-bf5f-b7d3a53ddf6e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_PreCommencementTenderOffer_45d4251d-ee9d-40e9-bf5f-b7d3a53ddf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_24ad61f1-6fe6-4f00-8911-9b2d7f44445b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_24ad61f1-6fe6-4f00-8911-9b2d7f44445b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d26c1c92-e8d5-4f1d-9813-5bf93461da62" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_Security12bTitle_d26c1c92-e8d5-4f1d-9813-5bf93461da62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3f81114a-f8e0-4e5f-831a-59bc97003148" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_TradingSymbol_3f81114a-f8e0-4e5f-831a-59bc97003148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_46e52b2d-5691-46bf-8cdc-594c8979d1ed" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_SecurityExchangeName_46e52b2d-5691-46bf-8cdc-594c8979d1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c10f624b-3547-473e-ac09-634579ad938e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_EntityEmergingGrowthCompany_c10f624b-3547-473e-ac09-634579ad938e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_dff8574a-e5fc-468e-a6f6-d01872545a3b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_AmendmentFlag_dff8574a-e5fc-468e-a6f6-d01872545a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_82f8dbde-5955-408f-bdee-b744cb04b533" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d68a9e1e-5d8f-4408-85fa-eb61e8396719" xlink:to="loc_dei_EntityCentralIndexKey_82f8dbde-5955-408f-bdee-b744cb04b533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image.jpg
<DESCRIPTION>BMRN GRAPHIC
<TEXT>
begin 644 image.jpg
MB5!.1PT*&@H    -24A$4@  !=P   #>" (   "HIU6?   @ $E$051X >Q]
M"7Q4Y=7^S61GWZT;@A! M-KEWZJ09/:9!+2VVD4A"XN[U@549%]"R#+90Q)
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MA*(N1$=(//ST1V>X%LY=]P=XAT,JZ9=0@8F=3^<?*"W-B_7__SE:H$?OQ-[
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M+U1Y26A&GFIR+G'T,19W$-C9R\WV&[K,F@&QM>KS]61?^+8)<UNC#H4[S 9
M1MN@CK#Q5B&:A6BA%VWFP..WK61+\H!\-RQV"/&Q$+O(K#,S_?9I$8WP$T6(
M[]_VDU'3ED[)*7KBWWH(%B*WF*$K&H(5>F6??MA>-V0/!&6HV9FE%:7U!_X=
MHN_O#T7#0K3* !"/7 KM)L"QDZU)AF+@-.2J6L24B24]H-^S&*6Q[+'H_%C
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M\98/R%YRAG]9YMRJ.VK^^)=_M742,R-J(JVQF1L3KR9& P'/.5 ,4(8A[P,
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M4%:99U[C]KTT*=6@(@>I\ 6_U3A9[)%>O/^\P[4 @S+0 +#V<Q0G@S+4X*0
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MP=0  "  241!5#H)]E<-5#M/0X*GP>:N3W;76%N:IW*0:\TI]@4M)P8H0U!
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M*A;!UPM&SE'<@C5WC>66=15S]>T'90X-RM1)[D;)49=PZ3W2C ;)49F:6S_
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M@Y_KRCSU99[&T9Z&4:[&$G=CB;NY5&HM]L68-\$":Q$AE^+@%/@2\"P](!V
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MUXXN7S'*U^GPKR81.^1+4Q%WX6KHFMR""V-F*@F&,S1TO5%+L M:,\XPD^*
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MM@-? -V#UHE<=2'0$_2A2#GGIJ8F0J/(;Z*21IZ8X'_9@^TEU1W,';)(<7S
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MJ$BWE[G6*\-[WZCREKN?.WG.BG'NY27>)KLWAA(<Q(Z!78*9$L+)T.BQ0IJ
MA$+\(=32KFYGGN:2FKC%U<0JFVS^CM&^AIKKHCNR=#TBQQH)_AE-I?0]VC(9
MZ$S>FC5B1J_9^P509M]]0J!,ANM,&5!C]/ 2K5P8,")T1Z ,/)P8\X01,44E
MNPXF(2W4$@@[I*;Q[KKC7+?]YNG=_92+K7)DFJ0!R^@_QB(KG!RQ\C8!53T
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M0<F&!K H\D)S&+)/<1: $!20&G?,*L6!R/A:6774/J>]N&+9=2V_$Z$, AQ
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MV#YKZ;&>VW[UQ-8,2;ASKF9DE'D6R;$??;E']EW=\1+#$,^4U:)DN)S"0^A
MBU07E'3/8N%*]_%4#T_M)HQF*Y@UF0]Y9C//;N'R)CRRXK&9CN_F2C^2]&@;
M-C@-Q,Q!.[)M<,!OS^U=]_HHW@+&).!-5<ZF>FEMY[M2X,@D[G]]FG/>.-<2
M^ZRE-F>3U=]NK^JB'')4Q\@KD"$R:P@!1&E,I"\AZU7XUE*"N6/VFC7,VUY:
MU5[J:9@JK3C1MZ#][N<VIVD8]\%7([EK/'^"?P3R!<2=?@3TWJOQ'LY?V\IK
MUSQVJF]E\9<7C/)$F0NJEDP*68+-S+F,>9N*@G%6'BN=\S]PR_3P"#S@/&J
M3O< *..-D&QM6Y&G>;QKY>DURQ]_+0DTG4IEI]0^PM9UT4V1?4I=\!%#Y0AV
MRUY7I4_[W'$<^)B@C%$.V2B<#">8?%]+]1H W-Y(L3\TQKE\BFO!R8$%#[^"
M<G4*Y[T# -A(?TN3,Z08!.(ZY0"3#!.!BW2%G^PQ_4^."SWJ@%5/(#)$0$)>
M-.?I_NQNDLSD_0ITF63.^U3>=>^;$V?=/,&SK,2YDE4V E:3$BS83<Q_ <H8
MU=\&I2SM'3_<QY$"*/-/]N?>?PY6'E4P$ SGE,+K;O_K^/)% &4"(>B8HL(F
M)!(H CQ$4(;PTR+/JHJY]2CY:6B;FS)]Y**2HUJ8AGOWS4<=*8 R']4Z!_N>
MB.!1+%U547M,6#FAT[>3\SL??'O*K.O+*I:4PGMO0]%K4:!#E(T3'E0>*U:$
M86B%,A)8I&A1Y9++EO[O ''"N,*UC"K+QLY9T,3@&^-GI$T"L9+35>6ME?@=
MOQ9 F8\#R@BFC%[P5'=FX)!+G2C8-&OY%,^BV=<G=G+^81^-!SG%L_V9%%P7
MDLX *$ E;G6,;- FZ].KJ3<B0!ET&,E9]6F\^8['CCWGQF-<2Z:5W[)TW3/O
M],$[ L])9-F3/YSA*.*\$PK!ZKDW_/1X=]VTL^;/^MJRYU\'.4H(D\MRI@#*
M',">#RJWF3-:*J6)0EPVF<U K8=<_WYB)5W7_*LIWN6.RKIBR';$F*L5DF#D
MDD+ 4HJ0#J)@/R;LW@02(GSMR$ZD&BZC?$T3G(MG7[MZNXRX%N><BK_",JI*
M^@"7>T3?SK<7*M J\B0 RJ1!A"?>IJ;*Z71:)RE  <D$4^C#A#TI6B:CI3/:
M_Y= 2JMJGZ;U<YX4.ZT,X5_]9@*(6-CPQ28O^H@VP3Z__&#77H))-60NRJH0
M1X32<U)&ID;LWC>G>I>.==>-\32/\X7MKA94QY!B%,D)$> B%&02Q-T0J:TB
MDH,%@+ #+ FTN>T$Z<#=/,I=.\%UVU6-][]#5*\TU4^#H4%VGI+)CH!DN7VV
MYS =5.E'G$Q555F&BY;F7(RN 8W_Y24^][9?3*E<6>9ML?G;$$D.-+*J9EN0
M&MS3Q2J)"T,T?AV1\8%9HY-KI"CM4053)LJDJ,4;'N6/C)ZUZ,PY"__T4E\_
M2F6K,IA3:;+O-!OTO)L\B9EANM]A.DT.?-%/J$_[W'$<^&= &4)DT)Z"?B\"
MDD)VL:K+415G%2M'N98?7U-_:N#6A_[1"Z8H?9U :9'MB\52-G)XP3 4NL##
MU *?Z-.0L1J$R,"09U58XZS"U90*@00$B&3>_8M7CO,LF.2K+:I87NP/%]=T
M,5>8U:QC7J0IB1X42K$ZN):G[[L/GH78\^0]%T"90S#45/ ?-9X<P J]B_-_
M.Z]QDM3BD)H(E&G#&D':\.@@O0C=/O"R_7:?-S:FJFW\K!ON_>NVI("621[>
M6 -S5N(0W-HG^)0%4&8X.A>Q)A7:C)3WFD:./4^1]DR&\K5WJ/R9#_BI54O&
MN6IMKIC%MQ8U%@<!E/E<3I+O@0RVP8! )::V<=5M$\ZY_L</O2T0;=I5BXL7
M@Q]NGE@SC4DQ'+<V'.?(NRJZ5'%]>,:O!5#FXX R9$4)O$,ZH9'HU,G\7:PB
M-*8F/MJ]8OS,[WRG]9ZM5-J=O+\DE40#* ,*,.I[$"*3ZQYB (M?AZ/?C\)S
MC!101AM 3E)*!E_F9T]L/BVXX)ASYG]NYL+IE8NON.TG:W_R]!^?WOC.3KXE
MP_^^(7W?$^\VK?W=G*LBQY7?\MF*Q9\Y^]9K5]R_<3?O3](,&^@775X 90XX
M( TW0N?(D$$%G2&5E?LT*I25U=2D#-K,@,Q[,G!TOMWXF\FN9245=39G,ZMH
M*#VOFVJD(9FPV!,I\;2!^08AJ$21KY,YHY $]L>M@0Z;+VJ3FD=[ZB:5+UY]
MSP91XUG,/E67<#_@!1_>#^S#-*#%*"]#-)V 70PY6)Y5Y*2FIA%!R"2U; JL
M%SE+0E="(@(KEK!'(OM ;)51:),V V*+)4*U@M-!2]P(!F7R.\0TK'N_()J,
M7BI(DTF1+IW,RKV<KW[@]4G2<H>SV>)LLSJCH[PQNR>,1"1W.+=W10#'($SJ
MG$GA3!LZ'00+.F:O93,;QM9$)@?K3_]&W:__D8$V!^4^8^5%Y8*,EDFB4T::
MRY#?C,/T6I9EU".D'XWR1U-I%04*-:!\&1)+O_,W;YUV[K(R]Q)6L=(:C%EG
M=S-G&W.U.8)=]@ 2Q_1@F@],&6,CV@9JC 0Q&MK;Y'6!J]DAA2;[FD_R+_[S
M6P/]E/^(NMT4OA,T&3'LD7Z*HR/MQ["'YG7I%B!W' <^-BA#+2::,2\1+\%\
M72RXFE5$K#6KF10N]H?8V0O'5"PX\QMU?WH3_F):X4C YCR9D@TW4A6I>*)B
MNTC#^10,:K-CAOQ"1"!RB(Q0N3=&9C:;)3U"WI>4^SCO^.7KGY-6C*Y<42HU
M6SVM1=6=K**-S5D/=Y/T>HVY /Z_ <H,97OOBQ5 F2%WX0'^ &G78,@KB/#U
M<[[FUZ\?XZDMJ8 2F:#)8!'101E*>\G#R/8+Q.1_1HK:O*'1GMJ:F^\:(#N0
M(1(WS3O >WNL>P>XWL+;>@L40)GA& H"(*$JD@HA]0/P*K-9N);]JI9,R4H?
MYP^]K)Q2M7*R%+&61ZR>-1:ID_221<I2@DEK*&<\AEP_H::,\:\S91R!!"M?
M-<Y7]Y6+FG?+/)4D(:Y<)^;@&'W9'([;&JYSF'-3H#"Z!VBLI@509CA F38*
MSR>8-VZON9TY6T<'PJ,J%T[SSJ_[R0L?DM0@5_JXIBI965;!_TUKV/AAIZ-W
M#R5B@W*E;T6'J_>/JO.,%% &!0Q5GE(0]NOE_)W=O&7=XU^=W3CMRPN.JVPX
MQKE\HO.VB=*M8SWS2BOG39*6'NM>^MF9-Y]8\;T+;NIZ\)E-.RF5"=0+U=C<
M#KGZ$L%^GR9-&1TDQG@=#,H0HIG.JOW]J9V&;BNVM IE)>SD?%[DD?%GWSJE
M.C*JNIW-K 5_P1^S>V/%'N R=J]>L=CBBEK=,58#K59(A?ECS(UM6VE%XU<O
M[-A.()R8C23P,?(V:?LP#=B>Z>60-=2Q$@\N9ZFH,PHUD8*&62:07'WRVJA2
M$FU&1;X6M;+8&I@ 309<$C)2IE'"-9B,FQ%L6W2K.G@LZ0U(C6:D9:'R6AJ!
MQMT*O__OVZ<X;[8[ZY@[9O&M1AC3%4,E9G\'TT$!JEF#.@NF[JP0U#1$R/2
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M@#+#TE>TUBHH4JNHT.F$K<-^*,F1M=Q'A9GPZM'7^,F^V@FNYF(W:E:BIFJ
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M[FJ:X%YU^<J?]9!?R%4MFQP PP/<R)'VDP-?]"L3(XK\-G$$!X8#E!FD2V)
M,T)N1C2L58J4!N)V+W+! (?Y(@Y?P_%52Q]^A1I.@UHSIPDF*YJ<(5&J3]F
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MYVE52VH\.Y !>)?5(/4RH/'F]4].JKRU+ # Q5X=8Y[F/$'9;N9+4%2SA04
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MD*\HWOS0M,%A7H!^JEMB([DDPC^10W)T2? <A*8-C*#.ICQLQY]Z%Y<L*+,
M3=EDRBQ (\Y_B?JZ1DLN5=.($,2V,8T LEZX=YF\$WXZ4L&C[J%ZI303H(Q:
M:( R'F48#CLR@3)R;GE@YZ6I6Z$2,O_-FH^7>@L(7@^%R4[&A3P1P5ZSJB;*
MBP_J_'U;_K.C\TH6[*/SN7 %1J;%I26<8B4-@J8N)>]3<I3A3.. JN7HN^!6
MTJO"H^N"6_9\\=$#1 >HU<OU,1K)2AQK-!;I$W!H7^I=LL#W1\6**&?B?+J,
MXO-)SI.?^^[RKBM\P;0_<A7;D&J)C,%K*3 * 11*05..FHH^(#1#I-9@TJL5
MG9*TT*A?&5J^X;(/#WYADO,R[;/<LBT30L.VC?S:H2&="!OG8)$%_HR'O-QO
MO(M8\NHI&Q&XO$)01LVR<*9=VO7%[U<.FOSKC_#?CUS1H?0OZR%"+^&2OIYQ
M,#*" Q#D@@+77'F%D%4F3DT:NM=:FDG)-C75%MR]*K3]#Z+;OO:(-4-+Z-0L
M5$:1L3=MHT;%D98H54/#"N\AD<J@B7/(YS^5?A&1&02^450+'I 3JR&Q-J,?
M)%4%/F.B@M(@:YZ)6QY=M^&BU:%=+8%^%A@&;JBDP880!W6TMJ,@4_<<&6&1
M%-N8: OO11&9FF%*E@43;;VEY?+P6=&^NQ[%C'B1\W=MN6%5*(532A.46; Q
MY#!EG)RAF)K$IT6=*G1$D0^P]9II\++-=^_[1GOGY:Y0K+6'++&"";@-*#D6
M ->L+M5,"@A.=Z>9G/1&<JLB^3=_8/QISB/_=O4*98@%XVZ%=,V(DH8<$KPC
M'9P.>Q:\Y\8Q5")I8A,D5H4&SCD__MPT!B(B(ML0-AD+UA*O\A=J@C(GH8/%
MS@9$DR@UIL6_\=.I%8$KP7@5/+(Z*$-,AP()S8S/ V5@J\K"6:\ZM';C!4].
M(1CCM2E.T[)LZD[Z["1\LL._9?WPT@1E#M\^QP_*I%NC!'\'BJR[T/+.JY#G
MD#)>.8\54B/.;SCA5M)8/QL%[Z(:U-EJL:[ZE)C_W,O.CE[YV;O_9YH0O6I5
MMZV:959)L8&*F.B6!8SFW/U<=Y[(^/"(3;>@?VB",O.C*"W=(6V__7O/B7(V
M\GX6K4TC@WK?6</$$%[0KECZ+U:?"&)',GY;   @ $E$050319L(4 8HN<VG
M;;[GBX^OE+?##5?.>[1Q4.[5^: ,B;J#_4B@C)*#GHB26R;U1_XA+ESKEWXC
M-.^PW@("E*&I(3C;^ ..?R8=A&8Y3U__P[6!G2O4C#\RRF02SG2J3\D"(YRM
M\Q@+;K7@DY,M4AR)2BW#HJAV<8>RR[H&UP<N+7[AP1=L5-#@O&6B),'!8<2(
M1%BA4\4CEK/FUX*U ,Z[M:H-2668F^C5"K</<OZ1X:^>+J?=YV271_Z==<&P
M'#P"%'= %<A+VS!XJBCTH)R;DG&'TB[(2&5 < T-K8XD5IZ[Y9-W_/<4YU51
MG&#7S"HTAH7 ,&W #:#-&6,+]KF.^$*+#,H$XZO#0U_Y[@OE*@[S=SZN_W[D
MBK;.;7XU[98++>%][)P8T]*>\_*0X($UJ0!E'(V2^MD27O)N*=8:3BX+IUR=
M??[0[O6;4Z_KV?ZU^Z=G.,RMQ#D6E3N"+V,9J&."^AH*?$0ZZHAM< K]@4;)
M(8@,@%G=LJ$R;G*K8L']K<+YBP8?O_'AUTH[UBHC+5U][6JL'5C8D*\WAQK)
M,!788CE"4Z-61:%S>'24J2.MT7V^T#A[1\P7&7,K>;^:]G?O>EUX^[>?@,)]
MU>23%C]_ZRTM&X:;H,R"CAV ,MA8ZF$'/0"Y'6@CM@#+ C7%J)F836_>O*U#
M'0;14DJQ4!H><)&2,!R8A\@ E!$$-(+/<J[@2$?G%5=,W/L<Y_N^_/C*P Y/
M*.Z<2U&^D?7)69],R#)LFQ+ [T#XA<89E7@@P;!*29UVSF4WW?UKX5)O6I Y
M Y+=_#JF%FB",L?43 O[I,:L$F/5T/ES.G_+!_*^T(@S_E\"RH0= 6 7:,X)
MKQ":">?=:NRTT!6?_]:S1%>HVD1X+^NU)BBSL/UU E[M.)DR:5=P")Q$L1[*
M19=6](9RI#E(+&F41T!2G>1$*1$K=&<:F#@]\"K)Y>&$_]Q+_KAWV[>?1&H?
M\:!1-TY%/NS0':"1(6N,8(0!(I'WZHC_FZ!,$Y0YYNE>GP5U4(9*28ABA@5Y
MQN0_^14_3;Z\11[TA4NL"R<-!$F1)+[!E"E1*C+MUD8\$4IDJ24HRP0'_DB^
M^%>H=VE^G4(M($ 9+)DB:TD@)M%5+#ZM\^\]Q<_>U.\+Q-QJ@77WM?6.HBQ?
MJ<?$*%HN0% #FAI%CYIKD>)^:=2G)-SP[2HQJ; RF/Q]J6_WQ#>%$EA51SU"
MX\")Q1DC$K&[269/+U]$?0JU[I*X54LW*P9.\K4:YG>Y9E>AW,SY1W9]9=5?
MQ-J[B":CQ5EOABD)IB7=:M(A-H,8(M0W\NYPT:ND?7(2BK^A42\\GA/MP>$W
M_]7(P]-X7<.H<;.,]VFX96.C%8)A,#3!E_//HK;+(H,RD>*RP+:O?>=I;O+)
M,@J.[GJL]B?OVMT1&O!VI;U=8\MZKR/Z1IR%4ZPG)S ")V\YAQ>DH<FEQMG&
MG>W1I$<9A<'\A@%O8.!-[QG^YN-@8E=-(;G(RQ5J/7PL2XBTF23%)F093T2+
M+EIWB>S('"(CREN<-8'KNMY@>$US7KSIT=<J_2W=HRU*SA>*+X^DV<:^]MX,
M+-O5./A<PCX,CA) 9,@H,,TV)UDTSH(9=["THO<Z5R#O[4IW!$?^O_<,?OT1
MJ-3,SE:XK<_H_%T7?:I#2C=!F07M;7"@L*0[R3"Q !"/G78<DB='*%*U^35?
M?G)5UQ4>*88P0WC A4N@-<E9;[18!V6P]<P'93Q:J4T:><MYVW\^">3N .=O
M_4!JN4J@#/!0Z&2UAK)^B3R;((U'.O0.*..(H;J5=%LHW;%QUU]M^<\#-B>I
M+*IB>G4<$!:T1X_P8DU0Y@@-LYB749=LUBADLFQB%4YQ_B_9>]J"NWU*78=>
M@^^[6TT@>09#!@3P I0A-AFDM5QJ<JW:MWWBSC(2 (:N@[!H4@7*8M[^<;]V
M_?#29,H<L>F.#Y11LSXUR;J'W)NO8>&]3!WW]^SQ!7(MH1S)"])JJ65=2LDM
MEYS:3PCDS7T+@JI+S?K"!5=P9'E@YUO_3^JA \!EL.8[J4"G-$FD_\E-#/*"
M"%U$CXH=GV)%^F]'_'2GSA^:H$P3E#FVT2JF *5_:!,%A%*?,)9AV2"0O\#Y
M7_Q]=KD\T*)D6 CZE."M":%?V+44<,Q 9#/LB2202U=+3"GZY=CI&R[\KR?P
M"LVO4ZH%: #,9>:=Y=(R^*S-S[OX^N4X\Q189ZPEFO(H@SZ(QJ7)=R8+'FRD
MQ")BIR\R)>.5XZU*LD6!RRR3LNY@8MW&[?\V^*49.F1R6[>-*4#H!FE".WNL
MH+A7*:C S32_%JX%+ M^]Z@4+]O3%=2B37&N6R;(+%,FW_R13W=L&$+!N1(#
M(A/.S -EZ/0"4(9 -R7K"^?\6LH=&F:A$6\4 JM>+<_>?O&_%>Z<Y!S0@8T<
MN)-A1N<*18GR(1OPPGVV([S2(H,R:O8TM>_KWWK2F +K:[I6F>+\:S^;?4//
M[K52_+3(5>R<M+MW O2B2!ID&6)MU(MKTH310%S&%4HL[\VWAN.LN\^E)?R;
MQIE:;(F.^S9N.RMR^;<>GH;HK\UK%=WF?)I^THFV3+@,+@HLXY2>+R#+0]RW
M7K4$G(D851 Y=LHI3:+)[+GYOG7!R[V!(:86/#U[F91FW4,K>W-L8Q^38NZ>
M(M!#I(4%309'<1PYD,<;83U()[2%T35KHE>M#:7?$!WZR@.SDYS/5&O<KIK3
M+\Q6^/LO^_R*[G@3E#G"M'J%E\6)L0'*4.PA1!_1T18JU[AN6%.<O_6OAI8%
M81[O[MV+-4=H\<*X.@W;\GE8#.T^*-!PJ5F_5FH[=]N6V(VS!BJ/JIPG/GW?
MBNZM<-'2\@)?;@V!+(.@)9J@8DPBYRO"7@0Y)Z^2]@1S*^7TZ8$K[WY,Q# 6
M(J-3>G:]PAY[9?^M"<J\LG;[+?^794 #WK"%5KH%WM^G[YU=MG%KJQRC:9)G
MT+=.0-P:*R3),P&V1NJ%"E(HJ::EVX,[/S1PXPP(S#A/ZC@-6,26_BWO<"'_
MNQ,PXB7K**^3Z<&O3:%?T1C')?3;TI,#ZQ#I]D)KSP1[>]]RN>#K3CF@C(8@
M$"X0<HGT"B#()50+ZM",J/;-,RGOW[27!6++0KM"'RD\-<NK@N';.&#6$1B*
M!D&?;((RZT(7^I4AXGLZ3.JC/_8IB57!_KYK?U2F646EWB(2G)_V$ 'P(N83
MFIHR"[^H'1:4 66\!M^!2<XO*GYC17!KBQ3W:6,.* .]3V&6)D3=DTP= B@C
M9P'*1"=:M<RZKBNO__JS9""RD/?<?*T3T )UG7#!6(&^0\7B5]WXX.K@H#<\
M 6Y43][7DV$AR)HZK%=4G I0!LD6/$=.N^14BY9M43+N(&3DUFFCX0_E)FT^
M+51+.0B-TY,H6G;\>G"T+ M[-G$/S3!X0;O;JB$)K5?T29N732HET&L5;G)]
M6J_J_.E9?LY?IU>I"9><8Q+<8<51QR>#+$,U B*2*^&8%$RPP'!;)+7LO"+K
M&F61O4S*MT4R:T*7W_"=9RKBOBT3XB=B7X!DE6-P/K<!+^C'.]R+B?>>]Q<1
MRCGWA.NX\,J$?E%8D5P=N/+>G[R(O ZY!E8I%/[&_;6SY>WKI51K*,_D# OG
MF)9B$<':@)@%])C YLA#*D\=ASYZURAA82.N<!(2,]TIIA;<4FQ]S_"?;-K^
MS0=F#9OK59Q=";P@$B)Q&NMU3+AR2L\7"(L(JK/($3@9,Z>/:E64MN@&WW/C
M8Z<'KNR(#KG"2=8SSN0\"\3;>_( B*5$:^\>UI4BB9 24Z$[2-+C5%P92;--
M:6C**'EW(-L:RJ^54V=+_7?<;T]Q/HT\7I7;L]RL&38__Z+K5W0.DJ+A,45(
M3,TVA7[G3;/#/W3&)TU*D2D5.C*F44%""-@;QL#7?[I_9>?ERZ)YIN3)XBW-
ME*Q+*[BU7$L/J64W$F_ W831-0R5_,'4NHU;'WA2!QVG:LY6^2\J_.SH%03*
ME/QRLE5*^"0HEP.4B9"3JV.13ODDM>25X?/J4<9\<K:M<\='8U]^4;B@@9BV
MB*'MX=OK5+W:!&5.2L\))AKT.[ 3F'S6Y/<_S\^4MRU#!1/-% )E4+4'?25R
M:0":29L[YI%@.F=]P?ZNCQ3A;T>+L X?'2HM/"D?ZPAOV@1ECM P<Y>/CRD3
MSK.N$=_F<19$5/_:S?GU\LCJ4*(U*&A6R&J0<60)ZR<R'(3(H *4ME>J70+V
MAX$TP4(E=W2?.QA;IVS_T*Y/H8BI4;/NQ&#B/B%3($ 9$8G5@QBA!/SJ6'+Q
M*>JG*J<L2VR%0JJLROESG#=!&1H@3G! NE@.R#HWH%_UCPY=U,18H5H5- 4*
M22L58.U[OOCX:8%+VI0X"U+YDG#%%B:4J&@0#MDQZ%!(&:84670"8JZ=.X:N
M_D$3E#G%1A$M%?4U$Z&5R2$'^\PT?U-XFV]#G+SQLCC8:$F7DJ@7MA1(AIWL
M+:#CD':' <HP.>M6"QXYY0L.K]5&WO+NH:>F2+^3&L6L5LQJI7YB%_N_R/R7
M<32KW\0IUH!+^G:QWADF.!V67:NA8TDH@2(NSODTYU_]V?XWGI?PG3NTHK<(
M*0=*4*-22?AH HVEN$W*NGO&/%K*%1SRR''LQ,H84\>8 N';/_^K'0=!E@%(
M8 I0QNE-4:J HL83U;VTQ,_O%.>-YZ[CPBL"9:@N)KTZ<.4WOO=KG.BY7C,G
MJ?(.R^:W'^-G:WTK0\.^"$'8<MJM@F9(&4L!RB118J..DXO!7J:6X)^MQ?$M
M)UR1,8 R6J9%'EX1V/F&Z+;O/#1;XZ@Z$Z!,34 P^!PZOD]Q1$;<ORC"XC9]
MHCK")#H(!94VO^;&^\X,[FSI'/2A?C;&>D&_!S5&BK'NX18USP)9%KD*3:J.
MNY2\5TD25S])9*4\ZX%2DE?.+U=RJT+#KP_WW?,8R-606+)G#6.:VQ5NZ&6+
MGW_1IU=V#S=!F?E39\$>UR<__4LG21PC#=.H&9P?L/GYEUV[4AD&-*P5$>)+
M:5]/R1/.L^X1IJ3(%;LAX2S<K"'G[%72JZ38W^RX&4?(JL%UG=O\8(5OG[C#
MKXPPM=0J)=M"9(^MD6D]"+_"SY4.%52.[9,*/BGO5HMLX_"J3?FUW5L>>!;Q
M--UJ/3I:L(9XM;Y0$Y0Y*3UK64@.Z(1L4P63S0]R_O:_&ET>&D#])ICL>2A;
M:[0>PHE,G+2I MT!9<99.._3XFL#%^(@K3ML1<L2!X23\KD._Z9B%:%=@G9S
ML5_@)WYM,F7$EGH<3)EPGO6.0?E.3J_04N%__=SP]4^]5MZ]K+N/F#)$Z85K
MI%AR40$JF#( :.;)MX%RI129,L'D"1;*+I,&3@]>,GC575-4>U%?^T4W":=7
MQ(ASO>GL^XW,S.%[_Y2ZV@1E&ED4\G!M"OT>:?C.30,\0\P!$798.HC<.*M,
MZ_P[CUIG!K:TA@;I4$'E2U2>[7"K8%B09-$4"P[C!!X90Z&*EELC#U^:N]M)
MF!_I#IK7EU@+6!8XY- !J=:X9=NV:5CZ+.?_-'#3:R,)=F["I4Z01442+B=*
MQBOJ M02*?E#*%'4)\-.+Y!T]>QA2KY%2[=W[7S3>?UW/@08X)!1)]Q5ZD6D
M-M1(9DC?MPXL.POT$FNF4_5V+$?]O@&*B/8G)T*=U\I<G^)\S\V/GK%QVXI0
MW!7,,*GHW70-)(&"(UYYU*.EJ$AMK,Y\3GN5I"AA WRCP:JV51U=U7WQCCUW
MS7+42D$=L]&)-H87U31A#Y[_ET5KT3GPQ7D+)RB8NXX+KPB4(1I1>F5HY^W?
M?=YTA+%%+0:$JZ<XO^=Q?E;/CI;NK3XMWJ(6/<H$2>C!%=[7FT6Z4DZXHWN8
M-"9 !!P1A<Y%&&1RMY+WR(D6+>614RNTV.O4;=]Z#$0R"_>+*&:V1O9$T/PE
M%3UH_I[:F243&!X<I2P;:D1&S:S6,%2L&I2/)FYY9%U@6TMH".-0CD&C)YH7
M7DM@X NA2@%R26/>R!Y7*.%3$FW1+%.2+%R$UG@TYPVGVT.Y%>?V_5%TQ]T_
M!T>&3ALFY>M$:(B _B\O^MSJ0!**L//#B:,^;C)ECFD6'SH!1?ZPADU&MTWK
M8)7_['F^NG.+7QKUAL%U$K,,XF7U;["?PD4(S2@%;#$J'KM[QGRAV.KNK5_^
M476V3(N+81AZU;3X [_F*Z7=+)AN#:4]W7%79 )8CR* &!+%"\=8. 9VIU+R
M226?5&"1(IEYQ5>KNP;VW%5Q9C<)XAS3A_P=?U(3E#DI P!D%LL&&99V"=2!
M'C#XAW9]KB/4?QA0!BYU#BB#50Y&=63)!(^SQ/K(CI^_",$_5$2@OEP<$$[*
MYSK\F\Z+))N@S!&;Z/A F7#&A6Q<NGUCWP>W?.YYSO]AQ^=/"UP"4%O)L5#6
MI2)71-I>*7<D[3BN0KZ-ZH7#1$U5TBV1,1;,,6G<WWN5NQOB,F<$M^RY]6$A
M^HM=%L-)M_1I8(@6T//Y,6DC8#S\ISKUKC9!F?F14]-]Z<@C>-ZB]E)01N@7
M<)O/&GR_Q5_7^2]MP=UN+5<W0A-+.?&Z <JDF3SJ"F<\&O2ZF9IC2L;UOW>^
MYZ)/@0#9_#JE6L#4C6JY@@I_ T<^P^;?O/^YWX_TNS:,M*@E7\\XBBPB*5>T
MY%:+\#0!<XIT1E"U!!DYGS+"NH<]D0*32TS)>X(#9ZC;BS<\,.L<S\%1GZM.
M<G !0.8F\IM5J N+TLA3O1YCJ?6[:&H!1S1^T@9)"C[566-RUH+US.69.]8'
M=K5+&6]D'^N&9W!K;\ZGQ%HC&=8Y@I.2(^>,/;A>W$2K@9QJVY1OZ=S^)^\9
M_NFS?,8 "F35ZH0YL>*8@&:$BNOB[[YSX(O3&X>>"9U0X)6",BA:D?J^^MT#
MID5L"PHUJ )#+]O 9>Y]FO]!SZ6K530FVYCS]ER+,V0H@=*;0']+-.-2LZA=
M@B,OZ8P*XJ'@"2MD$Q.,(^\D99:'4V=M[KOC@0,5SLME5#&AUJ-FZ6*:V#K5
M,9W2H P!=EROF+,FUZM5LKPA"*IJ\VMO_=&:X"4MZBC3XI[-193*2ADG%D1S
MD;(5DKTH!W-%)EQJMBV285W]/C6%4CMM@IUW-0O$VY3X^N#H&]2^>Y^&$&P9
M)Y>J1=9.#:!PAO/W7'S#RF"&3C+-\J6%6\B<V4?F&C!<PCI !=1&N3(ER/8?
M&KQMM3+L"L58=V(>(I/P@JR7H&(T5#.AHV%E/<:4@CLZSN1TNS+X%Q],_H)Z
MM#9=(3MKPS K!SC_A_@W6@+#;5*F-3R&TP5Y8^.!<,(.#['PD# 6\4DEKUQ@
MD;SKO#R31EJEW7\2O6*_!=G@*NJYFU_'T@)-4.986FG!G^,D5DU3MRS+J.F6
MA6+ H:N_M3+45R]?PI;M,&5@1@8;,I(1:8 R9'ZLICKDK5_[P;,U1(( 92P+
M1+8%O^/?Y@7GG5^:H,SA&_+XRI<P'I+PW RDUTNQO[WPNBF3[^<\_/',BM V
MKY3P*44F%X%H:[FV=XZST"BQKJ@*&]H%J(8#8JZD/5+&KY4\VC@+95D@X9=C
MWG=<]N;W#M[Q4VCOP3;2MFK5::H7UI&HJY<JS_7IW$YQ^(]V2EUM@C)-4.;8
M!NPA$\ !PAVFC,A2XB=))&Q\_^"*^1)$C:5<(T0FFF9*TM];9*$,"Z18..^-
M%E>HF?.WWM($98ZM*Y;*L[#OTK  6=7F.O7^^[;L;>O<R8+9EMXQ5QB4*&2J
ME1P+I!R0#N=)Z,BXU*1/&?$K(RWP&<T@5I:2'=+.CXQ^\06=\OMT:H6SKR@9
M<,[$XC!F"!\9Q.A-4&8Q1H0 900<(B8Z'>R)*:!/@R6#',:, 24IZ6_R:[KZ
MV<9$R^:K@:\%AOQ:PA4<8:$$TLAADI4)(X\-LHQ,2H%J$L,C,-RBI%9)N_]^
MUPV3@@YCUI&"Q@W8KPI0!AKGA3:Y_ZO?G83;!7$NR#=4MWFYAHI^/F7S;SY1
M/2MR^;K0Z')EG 6*4-W2<K[>;%M/FG7N:E&3;BE9K\0FN_$P"0!K8 NWA8M>
M.<^4 HN.,S7M4X=^/[K]SH<H.K9Y>09,1!1DF[91TU%K>&J?&G&HJ%2G28O:
MJL%$$QFUF@F.S,JNBUK"NYG6S]3=+)ID4LFK[*-C.2K"J ') %ND[)2D1TNR
MSMWMT31Y?.9 I0X66R/Y-?+0&]6=]SZ"KJE!07C6YF6=G"&<.-!&0=,[M]RT
M/-0$919Z&:(F)ILM4@&O@S(D(VK-&/SGD_R/WIWT!$99*-&Z:5P(^KK5I%<!
MZ4F ,LCJ*SF:$6-,RC$YYPGGW5)\6=<5$[<]@F2LS744I%6Y#;AMEO,OW:^O
M[M[:KJ0]6@G53Y$,J9X5P5P#Q#S$(@-4D)OW2B6W7&"!$;8YP[14>SB^YMR+
MK[[MB8-TEB#\:*';Y%7X>DU0YJ1TJH60S88!$^:9:1DZ=,[&;OBOE:&=!,H4
MA,P6SMY _\D8OB%$H!'902AJ*^E5X;[;?_!K(?8'H5^P,Y?6EUBNZ;::H,SA
MN^;X0!D07N(LDFH)C[>?,_!W%UPW6P6 \NA^KOSSN'_#5C -M7'6,X$JI^XA
M!O7H)#F]U$U78=T%H7178+0EE/(I.9><:>DI>=1,6S3GW7#%G[][UT^>PO9:
M08P/7,:LS.!,, ?*6.3')$XAA_]0I^#5)BC3!&6.;=C.+6I8V+"/$DM75*]
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M17_-;8^M[Q[P=Z?=H32.A;V4/]22KE#"$\PBC0]Y5U0MT:E2&$#],Z\  "
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M!0,FG&?!P=5R_\=B7Z*R&JI0/Q&&7'/@B].6SFEI[CHNG#!0!J05G.!$K-N
M*6VL-5#.V_NEQU9W;EFE)MQ2$O-N\[4L5&!*QM^3]2BC_IXLSJ5*'F?(<(E
M&0BN$VV-/+!"28^:<\LEOY1M[]H5^.C$TR: ]=F:B0HTBY,6JE@3=)JG!%@L
MUC 3'U:OF+,FUTESEV33;5ZU^;6W_FA-\)(6=91I<<_F(J2(0@+"HZ."0WXF
M?V)UW!O9XU*SK;TY%AQ@:IRI&5=TGRMZ->M.M2JI-?+P6>'MWWT*92D$N8.P
M8'+H*XB3!%9!IUB5^IW&0!.46:QN/^+K6B9Z7J_4H.!8M?D_[_[LLNY=D"W3
M2#@F'$,L$2FP2,&MI$%CD6,@SLCC+%1BX1Q\LN646TJN5U-=?UV:I .#J1M&
M=9KXF&+3$4Z".)IB[ZO3Q*C/(2')K1EN\Q=-_B_)KR[OVM46SH/AJY:8-,9@
M?);W]8P3&Q32:4XUDR,OG6_=O)<%$NU:^JS-_8_OISR'CAA'C#32;)H1=R*R
M($=LB5?Y'YJ@S$GI8&CG0T0;!9M<K]@5F]_Y,%\7O+Q-&JF#,N!=HC(4F;8"
MH=[PUL0F(J0)L*UD6^4A^>,3@/"!.N)X3/ACDRES4KKUE;_I\8$R$ <$J=FM
M9%\"RHB@:6X;A2*<0<1 @.PU.B=^]KLOM+_MXVLB:=85;^D= WLWF&R/3K!@
MUAL> Z0>S3GD+-0I"T2&&#1:GO7DF9IR;RKXM/BJ[NT?'?KR-'$;D4:OEFE%
MU2$V;)8AW:5C8+XDS4QMM*C!S"OO!3J"448?KR$ ?*2F$(?1>;#*^7.<KPM=
MZ%>&"*@2]**7^>E3$JN"_7W7_L@I5,?;"'8RRG7KJ781Z"YBR[!COV/GF5JZ
M0]I^^_>H-A(K3./FZ/Z=6Z_KW8IV^FT:_U3[OV*RB=P.?@*#%*UA&"9"C6=K
M_,\^D%NAQ5A@!.DC@#*BL!^"(W/ ISKJTA+N<)%I8TS)^Y61,[LO_J\G4,6R
MA+YL9&@M4Y\U*K"XWJ_S9V;XLP?Y"]/\Q6G^XA3?/\DG9_!]8(I/E?GD-*Z\
M> #?!U_DLY.\>H!7#_+*"[Q\ -^3D_R%_?Q7D_R'#_';?\!O_R&_^SY^SX/\
MNX_S_Y[FOYCE+Y3YBY-@X=A5D20TN5$QJV4@/7R60R)_<;^<#GXI*$-*$P!E
M++,J^$/3.K_W,7/5N5M;I21RT<HHBY:84O!I>UEW&KMX)$8>O>AWG+15ND@,
M*9^2.R,R^OVG &_3&X*@[JS@..XZ)*/?O>FUN'U[ E[=Z3*X8F*M!.>!\ZN_
M_.AR90>3XRXYYX/%4@(*G3UC1/)'#J2>BT/>6[@YP#$].+A,B__AIMV/OH!]
MR;0MZW<-E'%"&[%-8H+,R_;H.O!=@.#[OOSS-1NW+)?BOL@>UI5EFZ]%)E]*
MM*AQMK&O;5,>?!F<$LDPF/R8@(B1U%=;M !7+%0 7<647)LTM.'O,X^)O!.4
M3BT;6@,8.(91@Z;+W(:X&*,)9[-*==HD9E!-J Z3J,?$+8^L[+JH);R;:?U,
MW8W22*GD5?9!95 DT^JRXC "5Z RX]=2'FFHXYT%C*5 '.=G=4]K>&RU/'IV
M>-L]CUDSA*R9X,J433*2:X R6&;K*V$C6FF",HO1Y4=Y30(BC1KR$5;%Y@^]
MP,_HNL@?'/!&1)E2TJV-.,F R+A;3?J4&!89B(CO8]V ZEP]&1:,+9-3ZS9N
MO_K69U J*WJ6@E"CUBB1$PQ- F5H"1.=CP%O5[@]PTF!YMZG^/K@E1U*TA5(
MNI02"^\#(2M4\$3&ZJ ,A<4.(D/,T%"<22E/I.3MW#K^A1_CDY#B1AV4J9)/
M'=B%35!&S#BG':B,\+T7?Z:C>]@G"_(1 5ZD<B)J'.J\)(>^08!^J2,X\L$+
MKJD1V+#HP=)1QNZI\2<X=9AB5;?!&YNR>?JFQ]L[M_KE&%&;L66(8E@<CX&_
M0+;)J3Z> V72RT*[/CI,;HFF:>J0,J"=H@G*G!KCH'&7QPO*B-V60)F^#UZP
MMTJXBTCESL4J=3\3).M0*Z<;]NR,;1WD/'_K?;X___C:306V(;Y\\[5^I<2Z
M4GZMP(()%&+WB/Q]DH1F\L#!E1(V=RW->M*( 61D:-KEX75=5UX6OW.63"0A
M=8GEV[#+TTB'5Z= F:DOL(TT<^,C+\D'"+E$ S9!&>RC35#F*,/4B53%,QR1
M6N&!:U@VGS;XG0_R-?*.5K!@4BX-Q+9#0!D10ZM9)H\P9<2-57X,[$>I_X^U
M2YZ=QNEKB7UAWT*-TDSE"W^WY8;.]U_W]LW7O#5RS5LC3UT6?WYT[P.7##UR
M1>S)W;F'^[(/;8O_SQ6CSUX^^-]7CCPSDGENXIH#_WG]_D]_]OE/7?_+:Z^;
M^<]/OYC?]^3E_9]^JW+S6T)??I-\^Y]&/__FZ.?__\TW_.FFF_[LO,^][;P[
MW_O/3XZ,VU_Y)G_B*5XN@R^CERU R]:+U2G275GDYJF+:S8R\\XQFY8Y;M9,
MLHHMVRASN++PM8ZNW2MZ)Y@29VJ,18LD$E3TRGD<LY%=H?54%$H(4"8<\ZHC
M;=V#[]]Q&]+4)FJ:Z;U0(R;"L@9-QGGK1?[$S9=?P!8PJ!M)1Q/XJO'_V'L/
M^+BJ,VW\3%-S[[9<("$]_]W_;K[- K:EF;EEBF03-FT3OE1" DDV-(.->Y4T
MTE3-J-B& ,DF(=F$T$M" @0"!$( &_="2;() 5Q4IMT[=\[W>]YS[VA$"9:Q
M0(3Q3[_QZ,YHYMYSSWG/>Y[SO,]3X$?[]6.<_\N7DN.#$8>[K=I/PC%JD@6Z
M+% F1MR-& H;_2!QT!Y=A\T']9.ZQ2N_=^\A&*0CS2/SDE-XNJ_Q428",O2*
M&?*&CN/ 6\.4$0- G  ]EG 9[&MJ?46NI0V(;??<=GA&XQI70ZAVZ;50\)42
M#G\294IRF\O7@:U.M<R/";9$)BC#&CIJ@(PGV=)KF+NSNFGK-*75]XWN9XZ"
MN@=@#4K#*-RD[R]M40PUSZE]1GK&P-ZR!GH2O)9R_+LW[I@CKZ\-A)FR@2UM
M8_\195*K*W@M\_0.@3(PF<*26-1GU?AC=F\K8"EO"VO84G7.5N!04M1Y]OK3
M_1ONWP?WZRPLWS*<#^;R?7H93<9,ZL0"GE;OXN(KH,RIO==O^&G0DB)XCI/-
MWX;O/3;!O:I*[1#R9#8UXE3;8+04Z&6!7AN!,@XUSKR=#F4KD[HAY^SK<,@=
M4]6V#RIK^C@?S)*.-<9O05C#6%.,D$O#QEO9$.-4E0QCUX*>SW-^G/-/77'#
MN$6KQ\E1F]QI@T[3U>"@>>&X!)J,X%R;H P19SRAZN8>IJ;JFJ-G?G'+"WDS
MPQ&[GR3=3[(R%A7N#=OD'_0-%:;,VW!C14@7%<<&"<H<-?AGU]U2(VT"Z4P5
M(C(QI]IN5\.$?5MT2U\82(T"HB+SIVQJ9*J\;L.VWT#XR="U'++X0E$7-.BW
MX<)>YRM+$RD!1F8=(P8\!?F*^Y)(P$<@](LL L6A-A5,F2]<LCUO8!.N!,J8
M",CPH$JTW[2&8@&D+M^.W3GNS"NF^+K8F>$:J<OA2=0$$LY G"3#HMC9!0U?
M5"5CNB>L,(+E1E.4!3I8(&+WMDY3VA8T;.CZ\>%C&DY@,%L<'"2^C)8E<V[4
M1(O 7@%E*DR9UPD/[]C#5ERC['PX**,7>;K(5W7_MJ9Q#4H5:#,6H(Q*>&<@
M1DBG2*,3#E\'C- @VPY]O@GJIO_X5O*M*,\92<L7N9$Q,CD#X"X_,OC#?V[Z
M1;WT\'N"CY[N?^*]38\M\/UFOO30&8%'S@C\YC3E_O<%?_5>Y8$SY ?.<#_P
M?NDW'_3>_T'YWH](]WU4O>^?E'L^)#WTK\$'/JS>,??CCWQ ??0#\B/OE1XY
M37KL?4T/G];TT.F!!^:KCYX1?/2,X"-G!'[Q7OEG'_$=7A7C>Y[AZ0PW<IJ!
MO5R-(LM(KF#D[QT&RI@K;,Q;.*YS/0?R$ ?M_RCG__:IC1/E-KN"BE!XFC1A
MAF;>A%-.NN2$4Z&M+>Q@)P%U^TC>-1"M4;=,6[3\GIV%07*6RF0QE9-6NRX6
M/^9>YLC/O?(78Z$%\EB_Z+J6H4X#W&V0\[8?/SW%O:K.NZ7&%W?ZNP'>*9VD
MB(D97:RRK$X"$Q.;TH$2)RE<*V_^]*H;CA .4C)('LW+' )?S&\1(4\LSND0
M#KPUH QP 3H?,0 IZ%)N81!XH1M&NHBR:2P7$S_=-U_>Z#A[X^1SM[-%;?!7
M4N)532G(XTDA2_K7$KP0/MEJLMK7S=RH,61*A"W9;@]NLRULF[1H3?-%72]D
M>;^&$G!\>9&<N4>SW<6H+Y"B38[J.P8R<$'?>N.!^?)&EV<+"E6"+>S<"&O8
MA(6NW(6%MZ#)$.N'.A(YX*AAUMA2$XC70/<W5.V/,T^;0VJ;H&SY\+EM#QY"
M^$KG"]A *V8X.BI,<$KI&ES8J>7)CL=B3YB_4"HO6@2W!O\JEMBCUR_(2)KW
M9XV7B_R?/Q^I];4Y_3$F"^@VAK4B/*J[\>.+.)5PE9JT24DPZOW=Y*X:J5%#
M$Q9>V7KU[W(TM6'):$#,6M.THI!Y V^;JI:H<$E(ZH,Y ]&9+"_FBH8.A;<"
M!*%O^GW_M,573%%:;.X092])9_,V)L5-6!G"6 +QA'B378U4^R$WPX*]3.Z8
M[+[RAM_^)0.Y#?09ZY_0TL8IO8N9'150QNH.;^'_5C+/=1T],JOQ@T=Y?7"C
M4PY1(=X0*$,838I!/H:$R7QP3G0JD MD_J1=;9_A67'3@W^AJ8)LQHH\I^4K
MH,Q;>#-/S5>-C"EC"C\+4&;S%RZ^IL10$UVK?'NU])PZ&X0X"UQ[.9L_POEG
M5WQ_VJ(-D^4N5V/<I70B5X$,7!0Y"4"9"*T<2;D?TSWIRWC#MN8N%H@S?]BA
MM(Y7.R8N;C]=;OGU;KV/$'R$<>0N.B_DH0**&G!TS]*."[77J&\RG>Q=P8F)
M%JLP92I,F3?H158<%]776'91UT%AJL9YO\'/^FQ'M7<CQ/:4)%.Z"90A95\3
ME-G&E%Z;DJSRAVU*R.;K8G*7W=<YP;MV3=>=T&IZ@^]_BU\&3085&%J:_V['
MW?]TSM-S OOG!/9.\^ZL._O/IRW97^_;-5-Z=D'S_MGJKIG2W@6!I^>K.^=)
M3\_U[JSW[*KW/CW'LVN6^^F9C7OKI9VSW4_-;#C\_N;?33WKJ7G>)^=Z=LY3
M=L^2]\[Q[SU]R1]F>9ZN5W;-\CX[-WA@KG_W^\ZYYX/!7RSY&K_G$=1&0:T*
M.I2CKG4J;C"M20I8BUF+D#Q\CB%SP^%0<ISS1Y[ALQ=?7"NU0?C0UXE]%3F,
M/%A!8*WQ)JLE09)*P*\W"(#&KL3LOJBS<6W@@M0@Y_U]^!J] )UD,&8@F4R!
MTSP'2M2LE<];?.,K7W?2+5 L%E&C#C\QC1M0MNS7^:'C_'3O%9.\&^S>D"/0
MP[Q 9.P^RYW-E'.CB@,8,X6AY"K!,<>EM,_RK=M]C(II4<\RVO/H6 -E:,B7
M0!ES,0>%G;R6+A:)#$PU8@.<;[UI_VSW51.]F^M\,4 M4+Y(0F(#ZT/L;9(2
M!QD<F!X'"9L<KVKJMOGC=A1I0U>OVM<S48I..O.*X$5=^X^ T"Z2:T /F5&7
M_-(-5&CF23\+.N(W[YS9N+*ZH05>74M2L/V66FN7;F4+VT%["791618NTZ8D
M25 <U'KS,I4XD^*PTERT:7(P,E%:<UIPY:]V9?HY/XX:<R/;_S+7*5VC3F5-
M;12"T/N%^"L)5]-K%:;,2<>$D__#(L_FC"SGU_UR7UWC"N8-H79) N+O%-)(
MOE)5!9@I=FP)I)@L7#RBMJ:XR[M^GK+BCWV@7!7SJ$,2<LZYO$[HFP ]AT 9
MT??RF&Z!R/"BIA<0Q##QZ?QO1;[X2Y&)[I557JJB<D>@-XD2#V*B"5"&($+2
MN(FXY CS1)C:Z6A.351;/['LO_LYS^5-V$\0<RCM!BA3AM2<?(.],_^R LJ\
M#?>-]"3(?H*Z=Z[(?W#/0>=9EUN(C G*N)1V%S99R6@)H$S*Y@L[U7:7' .G
MU9=PJBVSW,O^-$"?DCT.<J7!<P4@W6.J2P]%^-)6AT@XZ=<*4T8TQ@B8,I 9
M,M5")WI:OG#QM7J!ZQ8#2=C46GZRB)_(8L0"SR@6<FE>S.N O:&A[CV_=YIG
MRS@YQAK:;=A$(>E)80RB)H@/VVMNP @>(A*;+N9I=_BB-<$H:VRQ-<9J&C9_
M9,G*>_>F7R[RHUGLG*'X6A-&>\@;2Z ,#;9797IOPQ!\O:^L@#(5H=_7ZQNO
M.F[%-?+($)I>R"DT SY$_)[?O31WX640'VI.H8;?OXU F0BT10(QF$0JVYBR
MS::D7. >MY.>4[=#[1S7<-6-#SQ_G(P(7O6=;]^!HL'3 U!XR6=>^LEM]W[D
MG%TS??OK??OKU>?>LV3W7.GQV>X=\Y6GYTB[9WKWS_/MG"/O/CVX<[[OJ7KY
MZ7IE_X+@H05-!^;Z]\Z4#\\+[INE[)VM/#W#^]S[S]TY1WZJ7MXSWW]@CF__
M;'5WO?I4O;1C@?K4 FG'7/G)F>Z=L[V_GRO==T;@?SX:X/<]R8^GN9$;A W$
M*"]*K4A%.:*U(,3L33-M$06;?4709%9W_W*6>UF-&F)RPN'KALF+U,%\89L_
M6N5+U'I2-1X(LU-I:)@U84L34[@2K_.L^=[MN[$W24+M1<ZSA1R0&7+C-0,G
M8K=8%(WR];Y]G>L?\INA0X:I%SLAO*AI^:R0=TMS_HVU/YK<N,KF)B@6*K]1
M5R".^*!T(S+XB/6@)B UI;9CT04KQ)C-&W(M7MMUYY^Q<,[GWEV@#%):G13R
MJ+.(L8E'@S2FM$(QGROH.9)@P5:GP;][VX&I9UX\W8\&9$HO:[J&^;9"[ G+
M1>@HEWZHH"G"(,<>!JW&':E6$ZRQ'6HL<GB2&IZP:(7_PI[#_= 7S^2AY"ZH
M3Z/9;[$VR^?UK,Z/%WGWS0=G>J^:&&QQ^$/8.O.$66-G5=-WD:(I\=HE"=:X
M'M4K%%CL2A)5D[1(0*:X9!N3D\RWS1'HJ99"4Z2U[PVLN/]@/LUYKD"%4095
MLF G3>/Y+,(JS6WT(,@+@R6]#_%2!909S5O_6I^-FV&DTT8_Y](%'772>B9%
MR20U62-%JB7JX7#: NQ(Q6M)A[?+YDDPN8/Y.B!Q'8Q5NU==T'X'?&$,7@"J
MJ.5X=M#(9300VFD^)0=T&!UB/9&ENY['_I#P441B0U)W>MZ A%/G+7NG2U?4
MR.NKFA-,!<7,YH^:JEB@R:2PKZM">-@E8TRY_"GF;H>2I:=CJF?UD\\1/Z=
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ME#DE-UC$JR$<^14?2LK6 I&$^@<@]6*&%R 7_]2+?(9G19T<J@KT,*F+B*O
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MY=VG^??-57=/]^R=YCTT1ST\+WAX7F#_3.G@@L"3\Y1?OE_][K\&^+,O\/3
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M#Q&)(J$T!L'21XK\N2S_L._RF9XU3B5B;]X.TYA 5W5S#W.W,D];%9B2PJ]
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MV\X:$PYO;')3RNX-.7P1)D6J%J^YN/WVHQFZST4=2S1*#S):_F2F@+>B1U=
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M,3E6Y^^8N.B*&QY\,0/Z=YJ28S#8=10N:-0L9J L:T_J>]3K1G@9E;>_/2U
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MYFT(\J!7 YI'PD!K$(N<".<[47;G@B&LB+TQA[=CW.(5VV_=0V49.@:"5?J
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M3"T&$I0!-Q53*2$"/H$(@#0QT;LA\M\/F@(AT,@L0.R()%3$%&Z)85'_$;4
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M]E)<H">X947X0O<5^5\X_\"Y&QR+USL"*:P2 ^"E([TF"6HL#@/TX\>BT:Z
MIDZ;0 F7TC[%<]66ZTG0L2"4 @JY@I'+E_P*\+6F^#168F;]XXF=/I(E()L%
M")F+OJU1$=.O_O#2?/_&*D][E1)WP':P$X*I2H0I'::CL*C3))-L@I!23.FT
M!5-.=WAJX^K_ON<PR#(6W^"$3^8?Z8T54.84W$UA3"&Z=R:7I=6F8>2U8MZ
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ML#ED!"AC,F5$S]4$309^G1@*39?_L%:B F"H-I;J5F+4D0B4 2X#Q6A32X)
MF1F>*V]YXO@Q6F;1&D;C6A9:3M1KZ8O,W1@<.)EP4A8/1=.9(W#H. Z,85"&
MKAN-@-.GPD,BCV@%/:L7L*9$D2B.:T81-C=?;[VM7EX]R;.Y5HH[E"[F3;'
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MBWRB.-?CNJXF.?\\Q;M__^98SXV%<KW5T\A< :;$K).[H=[E%8Q^HP0>C06
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MV78FO>NK7^<A/@$L/TKQ(U(,PK,&(*RB=Z8UTL@3I.!$FC^T\=/Q%:25(P<
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MSN6;/^/QS$)WV.YX/U#&U)2AY(6TQB^^]I9B=P!,&:F%R6$P94"6&0!E++X
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M/U -'$J30PG8_#0V/6U,:2\ZO<MRVDT_F%S??,>../4A(<J11K"A7TOM!<\
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M)",()<8LD_GB8WJ0YOP+C;^5Y./=U]K+5A6<WL9\(5858DHCUM)*.^$R793
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M?IDK9/6VYE5T6#W1HK*:LHM"GZ7!)D-MJ82*$D^B3J5H]1'F,!VDAPSJU.!
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M@F>:$'G^:2W5Q_E#6W:=Y%J4YVU&_DY5A%4$K>Y0GCMFE<E)0"(/J@08=9=
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M,64(E F3XP1!5_XQYLDR*5NE1)=+.]^YY6,'A6R501$R33QFCOSI/C95@<I
M&1I(R"XF!Y>D@II_2H6EW?M"MRUHV>[R#MB5!)-@ HOT)?27F*LU<\2D.07*
MI)@<=P7C]?+.S_T8^\H8F8O/<>,P]A9IZ!)K"8 RYKSV,BIMKOVIN&,:KFA@
MIR.:R/!KA2DC&L7<9LJ(5FXESUJ@C$I;006N'N)ZK@#?%/[MW_%S@MU5[CZ7
M+\[<_?.#"9<2MDM#56UIYL%R%7L#D&4@PRE+QZ,FF&)NT-;F7[Z?><-L;=\B
MN=O_D=$_/ <X%2P' Z /0B(S6_^E=9(**%.^ % B\Y6NV^Y[BH8M'5,?$0ZI
M: 4K'K;$]*K*#3+%*O7U4WY0&CI+B=-6E BE9R2P4<ZHP 7IVTM N+C($S^+
M0<D<E?2BEI_@JIETJFIH9!.</U$$*7WD:P^\Z3]V-<N;EK3V,\]NNSS@"D:8
MIY]Y!ZK\49L7'E7"F-"IQ(1$'WEL)^R>$++U6H>1][1^/Y*8/#'6,ECG"S4'
M=V:^_*O#HM T=7*2.",OK0W/V%\)!6+!/)HT,)<6?GAHX_G_.?#J*_O._5#/
M&ZX=#0Y\ZZK//##X@X?W_^*QC_\J?]OC?]A_[_=[OORU#1_[TC4W?/7:FV[?
M?/-W=WSAP9&['QRY^S>C=_]Z].Y?COWXEV-WWS_VXU_LO?MG^W_PL^$[;[O^
MXU][_[Z[-WWQFU=]XK9-G_K#YW[)'R<LD,A#N0G$7H:A4<[4C-VJ^<$8#JRQ
M3(37F,SS>?Z+1_2ZU9M<OHC-&W+XXL"8E22D =!]C@1E_&D63#%OOSV8F.?=
M]:XMGQ+Y?22=,-/77_G\TUH"UA9!:2 26AQ&L:#E"X;&BRIV%<8Y?S3'+Y#;
M3Q:4J57Z/1_>=YCS8E[G.D9@C-"D.UL:?<W FQKOR9>%&&'+_DY\KLESPWF<
M.%M!&7/N*TU,"#\$0U37(7N%+8L)SA_1N/=]B7.ES?]ZS<CO#@"1P0P&U;U)
M;A1,4(:*D68?,>#H&D$=945_V@^MZ9;:0 64F:8^S#U)(5YAZ8:9Q:9S?;*@
M3>0HBOCC8?X:?^<B9<@FQYEW$/XFIBQ=TA%(V7UA)*3 +S);$E\$]=*?9*U9
M1C+ BR\;7B#WUJW=ND3J6")U+9*[YBMX+)*[%DM=R[Q=2Z2NQ5+W(FG7+'DL
MEKJ7REU+/.U+W1T-RNZZU3L;+QEQ>&,07/-#I];N"[OD"/QW(%L;9L&0$*\U
MM[B0OF3J&K"U_4NDKAMN__5!HC:K1:$Z-,LT^*9I'R_RU(L$982"3 I!)BQR
M")>!B&'6%MC/Y(Q#"BWS[GC'YAL/$QM/A,@J+\Z2!P0G#(TCITA3P5T!I1/2
MI##P/<PU2 EJ^D2>$,Q['N6KI WS?8, 9;Q1YHG8Y+@KD!9)3-.#,KX$4^(.
M]\#\-3M\5XX]RR%T40 M=5(T%\'0,<,P:^'Z(FOH#'C;5(0@9O,**'-,I<YQ
MI@P-(Q8N8U4WE,6*\!-0#762'":PF_2LQF^Z_4_ 959W+?"'Z_P1AQRVR6"B
M ?T4L@S"O]C"93!#>2)D7)"%8F9;BH'+&5F\MN<#N[[\E,J?*B#A ?(F160)
MZKF<"&^.*>87/%$!94J@C!_#WY+6OEOO?@PR:D65%W)B=8'"-5GQT T!**/3
MJJ ,$*'WB)A]9IZM$-%<((A?+;P&8SQAX2<&8HYZ547"K1B<J$%K.:X5A%JU
MIFE%$JM]+F\FP68^_]\7K-N^P-LY7^Z=%PPS.>0,)FLN&652%'8)1"MUR28H
M0WKXJ2H4Z6#-)7N1AN>),2GA# S7M T[Y.A\N?>"MLZ?/\4/%D$T%83V%VRM
MK^P;4,3%0@Y)@E"KY_P!/OC&[;%7;THV;TK6;PJOV!PY;VODW,T#JZ[N/^_J
MT(77]UUPS:Y77;7[O(_T7WC=X&LW['GUM;M>=57/N5?NON#JW1=<W7/!U3VO
MOJK[U5=W7XCGG1=>U?F:#W9=\('!"Z^)7[@QLNK:/4U7]IS[H<[77_F9J_;Q
M^R?-<M>X#B8N?T4\,''+8CBCHB;2 6TS/5'DK[J\OZ8U:O,.VI68PY\A:T]A
MTYXFDW@K?0D8<Y2UQFR!>*UGUQLOW8U4:L*/31SPE:W%RK>]0B6 =F,.4J5Q
MAG*+*-^ ZE[C_)"A/:WS__KIH<:+KZ^1!XZ(+TM#\70'=E^D3NY_6_>7QVD+
MT)@<!Q_54/-Y!)VBT>)+!"N'SIS\C8OK+_L[LS-,G<>)LQ*4*2L4'%H%3HQ1
M@>9K6&H4*+GSMT_SK:%;_O@<8I2BP35X%A>-P@1-HY@_RW\LAFGYN=EP;#9F
M<:L54&::*J%&0%JB%DU&S)4%5#F'-:DZ01D9L4_]LJFEJUH.P[G/1T8!WB0+
M9%@PSOP#=O^ W1>&,; RQOPCV*6$JFL,88-_A 7&V/H;F'N(*;'J0-SF'63R
M$%.&F'^(!4+,%V)*"&>D"),C3(F 4# ;GN5(33!5[8O9W(,N;\CEZ:^2AK#
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MY+$J9:1V[>#REHXK0U\^P!%JD$8D6C $LA%@B,@8%R':;>ER9OI =%KC6?[
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M=7#9<TE[JCP]*_V=^[_R,Z'V)7;3"[F\ ?=)#'?P.R8M,"RET33)K=+<AZZ
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M+R-/BQ?',9/E^3-W/K'M[Z_J:[YRI&G3&"GUIIJW)E;"+TGX+F6 PN!!RC+
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M,--OJ>UKG-_UZ^>7K;ZZ2NZWK;^!N5..8)JD,\62AZ0S29^>S&=): 96)V%
M,U@3I9DR8I?3-;[^NK6;I0^E_Y2# YI**QRC6, 1K$B+'"L@[&?D5/#6K.&Y
M LI40)D7/PB;\SILC&GU)?;'5)[/07VE")N@C][]Q$+O5J<[[/ 3H@\^!5+'
M!99/2_<8D!KQ$ M[:,3&G/[><P+;OOWS0P7,T3K7\H9>*$_)$U&%%5J(==>+
MO_23?Z>A\^(D5R%=KVE%])VG^*\3W]]UP0='+NC(-&Q/+^_*-NR*+^F*+]DQ
MW+PKL73K\/*MP\LW#S=LR39O2Z_8EERQ-;5R>W95Y\C*SFQC^]ZFCK'&[9FE
M$ 8>7=&9:MB:;MR>:-B>;.Y*K^I)G=N;7-&3J.]*+-N6K-^4/']3QVO?SW]\
M&'J)Z*3"TWZ&01GZ> )EBOA2L:HU=$,OZ+R@<?40Y_X/[5^JT)I9)G%?N)8B
MY<0T:"1<QN9/VOQI1.'@R\2K N&%GNYW=']AG#91#<,H@DI;5/.'.5=5M5#"
M96A4$B&:BE#?&J5.OO(J?_%*EX"E*6.E+YF33)'S24W%GNYAU7C2X!>],[M0
M"C//$&L5FC+(7:+5%ZU&".-S2 -5_BC49)0L:]WK\D47KMFVZZ8?X5/$3RG"
M*AU8*(V(L:Q)]F3[BUB'6]\BXA0K;IOZY@I3IJR$SMS#"BASPKI%?D51+2(G
M7X>?"[+BM<*XRK&/\-9--]==W.?P))R!* N$G*T9XKQDL:3T$8E24$6$?$P@
M A*-IQ] OWL(MKYRDGG(\ *,N;G[B)-(>4ID\E(F9@I@]-J!19=FF;N/N?MJ
M C'F'G"U9AP!\LE6RD 91$?$(0K$;:U9%AQF2LJQ;J3*G["O[CFWM>>73_ )
M@Q<,3DZK$R38I>HZ]CFL,$F$#1:=\(3U>?I>%#,^+EI$ A6F#-4%L$Y,9(96
M+*"B!SYV5\W%NYB4KKIT+^)G;Q]2VX*$UK5DG=*(2X[8?2$6C $#A:^9Z&BQ
MNK;D0O?V]L2M@G6>*XQK7)TH3IZ^&C\-WUS6*6A@%[&E-;E70)FS#Y3AIENH
MM;XRE5*YRG/C!8W?](T'ETD=;'6(77(3"R21G629F<#/Q/0-A%8#W&Q$GJE@
M-1(HPY2LW1^M"_0O4W:^O0MF3#G.<WF20=0YS&AU[/JK^8.J-@FEX2F7>D2M
M%?<E2T.N(O1[XM'2I"MSE?0C+-*RN0XJY@LY@S_+^<7O&:KV#C%EA*@3@ET)
M%TP21J(L:Q.1@9"U20D+1FS^@7EKMK9G[\R+)FD4#3TO0!D:/TT:N3EMFYC!
MB2_W9;Y*? W2-38,#4AFGO/?&GO_/=I][D>&EF^\<=7@\.+NL65]'VL>S-1M
MNV'YSOWUG7L;M@\W;$O6;TLV;4\U=<;K.R*+MJ27;A]>UKF_?N>^Y9TCR[8/
M+V]/U[>GEF\;:>[*-G0-+^O,U.^,-O7$5G0/-^_:NZHGV;1EZ'5;HI</<!"'
MD"XQ62P4^<S+Y9N@C JY5FM)0LB(4 U QMK.L1\N]W2[E##SQ84\H5V).8'+
M4"<B4,813#,I"M9?6Q9TOD!TGK3GPO4]CTV29A#G^?PD7!K5<6ZH0LZ9JA5;
M0^9R&B%^!91YF0WX%?YS8+7F_AL6:B+(ACZ1@1F'/Y_G=_V>+W/OF.>+,_<0
M9";\(']2^EN,Q@IL(]M\L6I_&!OL2HJU[6-2LEH.+;GHFCON>]Y,?YO*@)OV
M!DL-]V01&6L/K?Q3S<6-^$R\@!,54*:\B,[88ZLA41L0VDCF8A?+7K-U02:0
M4BT6>X;,5(OR;9[C'\_W]EYQW8UY4L8VQ<*F<DSP;=8JPG)[G'7E+&![<MB%
MJ81J%":YECM<Y/<\RI>W="SP1IQ2W!&,0N1"BC)WU(D,B[3(QB<0G_)W_ DF
M1UV7C#F"PS;?L-._EZW-..1]3F6?W9>V!>)S]8&="=J<\&=@1.@?I>>,W9]T
MR.%J.5RC#-4$8J $*G'FC<.'5>@4P!I<2/\"K09@[1Z"M4<PPZ08"Z:KUPT[
M/:%YJ[?OW/>#@YP?,L75)[D!IX0I)!E-M$QK9M:UG](%54"94E$<<2 6C;JN
MZJ2D]M!S_._^+54G(SV<^<),'JA:EV#0S\XZ_#<XO,,F*!-(L2#TC*B+D7ZV
M$J[Q=/W#FW?_[CG,PL*K"SZ)9]./-9Q:LWP%E#FF]L^J]"72;+*&2UIJ"+4&
M@D$GN:Z-:WS@XS]9HNQA[A#\[^0HUCOD,$L;#.A9E/D1L?G#-G^('F%!D+0I
ME'6KQ)AGH$:)+/?W;DA_]RG.L64!!6^53TSR? $[&3Q?U '*Y$%&$#\XJ( R
M%5#&:@\G^-\:U81_F,FGH 421*PG"<(@'N#H-WXYKZ6;N854)]%DA X9,EQ
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M=3#!_)#"JO6%E[JW_NQ/!;24 I4/YYI1,"B3TS3N$>6&XA.!P_&NM7)^]I4
MA9"4'ZOR8HZ3F/,ACF;SE>_\H7[-MGERS.G+LI:(,Q!C<@@L:Z0N"N6I+ S:
MD+4+]!8<*RD$@31O>'/JOR$HH^;1&JV?4HQ5=LYZ[:7_+T:VLK\W>\34>9RH
M@#)E)73F'IK3G!@#*Z#,414MTI>P=V#P8@ZRH0=4WO*!_572(,#Z-BCWV_PA
MR!\J,0I;1X#+^-),3ML#V2I?RN8>LGFB#E_:&4S7NCNOZ__481+S+N@8^B%2
M=]17SKU?K7'CB-%*ISPCM0@*(>;3YU3^K7L?.]=]%>CQRDB5+U.C1)WRD$T9
M@I2,/V4GRRI21XX@+248(241N/!4R?WU4M>]C_%)\D90"]CO$/&]:+<6'"/$
MVF9X'^LE5E %E)FNX*RI1^, 8LQPB5+XQSG_EW_OJ95[F3<!.S,Y#2M#:8CV
M.Q%:F_OYV"TG_0LEPP)9NS]N=_?4^W>=X]UP[Z-\'-%FD>OC*M<.:*#-3*I<
M@_V"J10)"CRN"Q$O40GF=G\L=4&!PI@W@SM$)ZV ,F<=*%-:W:"13PL[FJ.E
MX).,<S[TZ9\N6;-IH:_?(4.MR1D89E+,#NE,2C@-$AO41WYGA*J36U-$&#.!
MD0#YIQ%HM+MW?63@&P?S8H58, J'B[R0(R,9K'E**"EHCZ+WJ2IA1CJR)2!"
M0TR9:RM,F5)?MBPJYW[(,-U4\-+/D>H_TGR*\%KA?WQ&/R^XP^7I9[XH XLR
M8?/$;?(8\^\C G/,I0Q4*P.41RT\(&-.>6B^-+A WO6I>PM_=5\VBN09AHT"
M8!_F)$5=Z*5?Y4OXR[(OID8@<!D!%1$H@V&=?JPAWFPK LLKS0:BP90_FQ /
M!?PT-] ?OH1+/$5_8LEVD&80Z'SX7$+<2/E%TW0$D0<Y'_KX7?5KK[=+/<PW
M5!5,V;T)YAVQ^T< ROA[[?X]T Z0QIB\'_@Q5MUA\HU+5J_MC'ST>YK(E +.
MP_,D3D3Z1 1]FKP] <I8!7N*[J_R,3-= BJ(T;I:G( (E*X=R,$S(F?P=V^]
M:8F[T^$=8E*:26E7($E2,K3A0*1KNYP%WTKX1ZR+,U_(V1JK\?8WN'=]_1Y*
MOX6.^$RW!VL152HFL^]/G<>)"BA3*I\S^4!4>CEST#RF$,YLBF>M)386_P;(
M+"@-4AV[\_[Q1>XN9S )%+XU!D3&/R"R% '**",VF$-GF9QDGK#3$ZI1(M6!
M) ( ;WB9O_N.>QX3\:BA0;X-(,/<;EUBU\H:LJS42['*U7FA8$"Z]5 !J4SC
M&E?>L:?6%V;2\/S6L:J64)4TZ R$F4)F.CXLO&'D!$'T$BB3MK<-,W?_(JGO
M/;N^2G(R!MEYZ 5:QHN)VXH^B@:^Q[J8V56P%5!FNOK VLS4XQ6$4VR2:=B]
MFRSRC]_Q:RC+>$+5P5%LAGDC;/V(E1@(B1E2EA%"VFGFR[! ALF16G]HH;1S
MR9H-'QZZ_3F"(_3#3ZE$SCZH ??1M1PGZ6[L&IJ@#&(UVM"WMF"GN]C9?\[J
M""8*8PXN5L1> 65$I'_VN"^=;(LM$*MQ0^);2]>T5UW<.Z]UF%T4<@72!(;&
M2)>#EK% 7H3&$VTW!K#+:/.'D,R+== (4[+SY%CCVLX;/O^;O!G2JAHOCAL3
MID_><4&9HY@R%5#&7)I"^<(TDYOC(</)-LH7?+_ 8I"80Z#,!.>7;;IYOMQ/
M?K>P=63N&)-&F6^O!<J$JN70$:",%)ZGA.J\N[;<>.\$YP7(@XJ\:#.MSBIR
M*SA^P6N:D3>(8+V$I-!WE(;\:0^LRQ#7CV?K3F97G"0N'BT<B(SI<F4F'NI&
M$9K]>8Z$_Y\^S%_EW3!/&6!RV!F,@^#@29)U3I3YP\24"2/!4AD3H P25?QA
M6R!:(^VZZ#\&#JA<I:";N-:Z9:].Q6)>@Y@[K8*K_#\72@!D:U#F"YJ:(YXU
MFOEAC?_T<7ZNM'F1MP<B4U+"%ARU^Y,T+$1(3(KD"15H2SEA+!)AZV),&;#[
MH_.D/?_G_\6>H@1!<P=O9LMA"GPQO\?J$:5^BA,54&9F:V&6?'H%E#E111C(
M0J5U&@S6D"3_GIV?K5K=1;+]I-Q/0#PZN"]%H$R6K"B2(,LH<;LG5.6+4%0P
M,,^W)[CQXT^KZ%GDY90KZ)#/F)HD3W0AL_:UXX$RP" ,7E3QP$HX3X^;;GN@
MUMWM]&?J?&G[ZD&7'('ML1)F0928#<-C@L9,"+@BO@?G*%$33-5X^^O7;/K#
MLWQR4N0KF1^+XC.'+TZ9YJ#!S\K"JH RTU6+6'%@K@%31A7=@4[F5&3Y_<M_
MAN9+NY&:Y!N!#G2K90I#0K^4%TQ$5%@N) '*>",UP7B==_>"EO:5\K;_>9CV
M.=6<1LWOD KD!=^C0X1(J.F7.J 0W9BM[6>ZTCOF7%EOH(%=W!N>\6L%E*F
M,L<TF2-. $#G_.$B?\NUGU@I[:EK"56W9ID_RM:1"RW,F$A-!BJ_E#.H6+,>
MSL *C07#X,[X$DYW>)G4OVKUQB]\Y\G#*L]C_9,SA,^NJ ;"0ZF%0J>UQ$C
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M,8/3SQ&@C+4G-U-W.O.?6Q9?4[%60)ECRKP"RAQ3)&4GQ)RO@<8Y;O"O_>1
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MH0@&W@R.J *46=%]1X-\X (1&:9D:Z#,TWOT*OP9ND@J__*#)ULZMX&N',U
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M?.DE ZD6I,8M %,3:^0QSE>$;ZV!,F766RU]Z5QV>]IQ&+'&?_PD;^G<5I=
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M0SZ%P9]XDO?W_TM[Z/5!_TTKEVU>V;&UM>6VMN"60&!;P-]WX:]E;0/MH?Z
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M&@;@G,$?>)A?$]WIDT?=,NH!804G.4/QG?Q.2IJ@K2!1.9!+[Y3S=>'Q0/?
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M[V)=*2:E&]=-.L)#]5"4R#+L'P[A1:I2(GT)4&PLSZ+)1B79%M[WRLWO>\I
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M"@6 A(@)K>:"]TIRLT(Q*E^5M)AWRTE_9."V@Q^<YWQ!;.[T!6[,JR5D,E5
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MVC'EA&3:UJI<7^ E=5[EGWC@1%M7/TJOKT49'0)E,B04D@(J#VSO")./H"Z
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M<;YIY%[_7VYI4W*.<)KX%S3=D,8X!6 %4R8+.:O(E$/*N^5,O9+Q*"D6'H-
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MS/WD@KD?PS'O(POG?GCAO ^>,O=?3IGWOC>=_:EKKOS2;WZ%50_);6 ,P@
M( !)1$%44XAYF+I5HO6#FW;,T10T&2J7(YPI\3IE TLX<PXD5%OTZ(U>(?E
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MFYF@3&V H9V< 65;IQK<3[^C()W)AS]_3Y>T!88TG'&C%$O!%1T5\MX4EW-
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MB0 1BH:]T- 5728, BR&T%41V[ C_IU%^[":C1:XC.WL""T]\4HX9LG@?SC
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MT1$FI[VAG?/#5SWX!Q!?R9.LJ7L2'X<NZ8 RPKP?/+EF]O XX7>/DMBHJ&E
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M3GE'I[QCEC+0%1EJ#_?/4@9]@0&OE/"HN18UWZ(BEYM)29><<6Y2^$-.J!/
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M7;7VG_,"VS#_5W4I52"I@8@=ZD7*V(IVO%/5SBHK58V J9@5WKZZ]I#%6)L
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M\O$U_S:GK!V)5Z-=6"O#_50]<'>6NCLC2* A0!EFL,)]XHNT%ZA-JVKOU;@
MS*RR]/;= 3EQ01DA[3IA""T&7 ;^++%U\(?GJ!N1SU7=0_1AEPDH=15FRO3)
M^*9H;WIE'RJ'!-MS@JWGES4U#_STB!"'=5S<$C$'(IF@'\7T2?,>V8@LMU/:
M97#2(5)IG"^$0!E3@C+/S%$WHH1PE"J<@/[#:AL!$-#3>DGW0T:5M$A'1J0S
M)[3E+'7-J^3PD\_R]FU^FI[!V.X(Y90I+-O&5<_2(AW^4 ^-.');0KE%Y2D@
M,N'=1 OM@JLIV *F#)OS%.DKUT?\-PO*3$V/DTZ@)9*Z374B'%LWXJS,.Y88
ML<4__=_7%E8TYU7T**5=2GFW/]K+H,RH!&60E7D,'"6-E)#**09E4ES9R% U
MNZ6V !+-(%(4B$QZ95]&97=F:%NNNGE^=-/\LEL65=UZY4V[.N[[\5._U@^;
M<)4@81>-,=-$_G3;-C4M@41P25FQV+%LT] <T&8U(6*F.<R Z=2(Y/1<U39-
M4S= !=)IYOWVDS]?^"&U:&EY;G' ?W' 5QQ)6U(EZUB75/L61V7UZ\51*J5$
MR L*,%529M]*G$#G4)VFJ'+)%<K2*_'UD@I?<2BK6,TM#LPI+LV]\!]77/'Y
MG_YN..Z(H1A!,?!GT!":GN>>F;\B4UI:PC(H])U-&=OAR"_'0?)]5@5T1R0)
M7GSQ%;/O*T]$/[_CK+*;"@.WSZG8KI1OH\5X-U>']85[_>$N5#LB1(;7XW$%
MDJ25Y2HK'MMEC"C.'Z4P:,8!-QSJ[W[*AM#1>_!H& #R$OWZ(AWI412J3%-;
MT\IW9)9OFQ-H/D?=^+[ ^NMON_?>AU[ZXQOL@83'0A>@.$(=,6TJ=.HRB01:
M1SKD/<O/.YB98G 2=WT\(_.8H,PKA<$-J3/JB8_]X79B.Z]Y[.F_>$P9:'*R
MM5EWH1N ;NH2-$[B86:_>M(M $R$Z$MD+J)SI+F;"LIH0JRN/W1.V>;L4.N)
M92#UTT*U\;JZ/M/RC!.3*HJZ @ 98$0&P_,=C$@'02QL]M@V#IVD(XY8XLZ^
M[\U??FMAI#USY1YX/B_K5V!^P [/"O9F!,D;3*DZD$4U#%*>$MJ5%MHY)[Q]
MT16-AX48(@J"J:,-9O].70N,,4W&,K73\F:;CN78FHWHZY@0A[[STOGE:^>4
M;LH.M?K#KE,AA>RI1#I1IR]$N075SHSPSLQ(;Y[:OO#2YO*KNOYD@!8=$_$1
MYS7#^1NE0/)9I$(/*7VGH RB23SQINNXH,P0E<2>6[8Y)]R4$=F2$6ZETF:0
MQFR5JB]%>RB\CM(>1=M]$3A."M7&:^KO'1%8W-U\Q*>N?V;&+WNX#)0$1"ZA
M?S41.R),(S&*L/W2ZSJ4C]Z>L[*?PJME@;DQ+Q0C%T@]V9,>W852"2@[T)T=
M:#N[M&EI>,-OAB"$5 QKU($H25#&]<Q/(RACV>S:')M.75!F6(C&@T_,#:S+
M"35G1G;X0ELRHCLHT2_EP [WXMDC'1GAUHPP^><BK1G1MIQPTWQUS2N$6FJ,
MU,^,3C_&77) P!$A/K'F:X5ES5GA[;XHGC0CW)ZM]F0%>V@ PO_'[&^X!L/;
ML\);,B(M16I#3>U^&;[D.IP@2F.@# 44'N-G9]\ZV1:@$@%&,IF$,U4S@#P*
M,T:9X[;>]TSV1^OG5O5E50^D1_H* BV-!Y\?=<'0%% &<R\O'1R^-#9 3O;N
MCOZ^4J!N*5";9_?';('\8'.NNCDOU#0GM&F.NJ&@=.W[+V_\^*WW;CSPQ$,_
M.?++UR40HYO,!66NE(;2Z(XF3 WO.@*!HHX .\;1"8Y!JFW'UAV;"]\=W24S
MZ[661$X9^$1ME/?3!:#^1Y]ZZ8(/J_.6E.9<O")S42!S2=CO983Q*F&C]-)Q
MJB_A?2Z/'07+IF1E6G&%[^)@]L6!_$4KYBY>OJ#D8WO^^1$D]R7=@C5?(Y'D
M!I]9#3C-=^O8I@<Q.)8;O2S#O@B;,9,4I&,*6^-H'=,B!%&(%_XLNN]_H;+V
MKG,B=Q2JC7G!ENQ0:U:H/2O4P9N?BF<?)V<$^<;=2DGCV!,5]%$%X3+8$P5F
M;,_ON(#..&;-6!$HLHY@(!%'IB,CA"TKU)H3V%(4:BD*;EZ@-I1<T?+I.[]Z
MWV-_^,UA/!%\Y BA!N/%M($J IJA+,A(VZYA =6II 9[>*9N%IYF&3BYGV/P
MY:W7X/?=3ZFQ?O#,[Q>6K9GX^E*H-LY3UU]0]L4?//5'FCO)J.%V)PN<>!FN
M38[N8K#LK3<S^\YTM@",%O2/'"$IH R+@X-UX;KZO1>4K9L7:)RX/)Q3MOYS
MM5VFZU=DU8J7&^^W2 8\JW5R3\V>SR0*7UBF;7!JK5=&Q#]$;[DHN*'HTCN*
M0EO]91OS(ENS0YORU,WS0MOFE;44E6_)"S7FA!L*U*9"M:DHT%@8:,XJW5(0
M:CE'W7#'P/_AHDO&K,D[N=Z8@K,AD!#!L6HRZ&HO(S5-_W".B3<=4;IJ\[FE
MZ^:7-Q0%T*V%:E.!W)H+U.;<0%-AI"5GQ<9YD>USRC;/*=L\/]Q:M'S3^Y9M
M7/2QFP\\]-P(M)&8*48=H2$NRI5\%S?T9JU)/:8M<YEY8\L=929A2:MN.;!P
MQ;KYZIJBX-HB=4.AVI@?;"Q0F^:5-\\KWY(?;,X+->6'&@J"#85J8Z':4*1N
M6%BVMJ9V7]Q!\I*9SER85%.>W,GH3M80W'!:'0J2%A-47+S_&\^?7;X^OQQ3
M 6U;8% $6O+5%M[/">[("VS#R]#VK&4-1:&6N<&6HA4;SUUVVV*UOF7O(W'8
M@3:8RC;<NSPUG0)0AKG J?)&DFR1LMVR_WOGE]YX5F#]W."=!>6W%87NQ.R'
M88+GQ8.KC?,"$+-"M0'R%FJ8KZX_K_Q+K]'79_J,R$SS$2%6U=]S[HK;B]0[
M"H(;"H,;B@*-\\N:YY4W4VOP @<Q* HT%JEW% 77%P5O6UA>?WWM;LJ8#$F4
M7 O*'Y R1= L<7*2.OOMU!:P'-O"$D#MC:R_\+M2#0(S;B0TXG]]8=L#"]2&
MS+(=F>4=18'F30< RK N(R,O>!U!T0F0YOAJ/$)3?^O=.E96U1U:57=P=G_,
M%EA=MV]+_Z/M!QX[\,UGOO\??_G=$3 +8[11B"^M:MQ[<D\(NB.M670?OP^9
MT"A6G4*/\9)&(I_P;G7FJ;F.K**')R5\$8P#(4:%V#[P+Q=^M#)OT;*<8F29
M4=ZW0I)?ED8I.PR5OEY:K5RR$J%)'[P"9!F\K,*G2ZM\'UBI+ IE+*G,+ [G
M+0[G7K1BSOLO/;MD><U-&_XTC&1Z8UT@'YSUH%/3"C/D5WE"H0I\7(</>]37
M)#S+]>9Q0Y)PVBZHS_09Y)VQD 3W:]_[5?V.;WSDZBWG!&XO"&S*#>W(#'<B
M*6;5'H3[A;W\=L3=C>RD HH[00L/=J#&?*C=%T18/@@UJ+*4$M2  M@]2A !
M_,BJ6-%-GH=.7V6/O[K75XD\>:A &6KS5W8C-IN &%^PS1]LSU+;L@-M>6I[
M?K MKWQ'WHI-\RY=5_'%P8;^'WW[V2-#)F0FJ1-0SGEAW %*PQ2&)2M>GOK%
M:R?K8=P").;>Z#T#%]'CC3(I-)9%J=$<D8B;/__UD>MK=T]\??E4_?ZKZO=^
M9OVN%UY\%3E\J'5A4<G9E8U_5TJEW3-#1MY[]39I/,A53OX'28!3T2* $]0[
M.VF*YK[[KZW;O:IN_\3EX;K:@1U=7]&)9JJA6J%IF @,@6#(<>CJ6^^0B8#K
M$$AMD+\$%+D?/OGR_[ZY[W,W#5Y_\_[K;MY?4S<HM]K]-3<?JKGYGU;7WGO-
MFL%KU@RLKAN\KA9;3>W^JVL/77O+/9^NW?N+/Y#\FQKFFIENA<QTH66;ASR;
M5#6#N'6V 5R&9A%$!UF@,PV;XIYO_>>UM?VKZ_:MKMO/&\DJB^O!3]5C<T7W
M$-3%VGM7UQY:?>/^FB_OVKSS$&7WU6SXB8@R1OP"4O+("4<Y(URAG42S>DO2
M./N<%J^X*5IZ'[Y^S;YK;]EUS=K=GUY[X!,W#WX2DCFXNFY_32W?[?[5=?MJ
MZ@97WS184[OONKJ[:[[4U];V=7"U.>+;7<\F<4]GU*ERZ>$5'^H!D66$85&'
M0);@O'G3$<NNONT3M]R]"BV/QE]-VZJZ@ZMK25I@9\D-8H/MX.JZ_9^JNZNF
MOJ]V8R_R,@I;F$F!!'98^3PE1-+M7&&>TN9/D3>V/UT[1=AQP_G:MW_RV35[
MKKFY?]6Z U?5#M2L.UA3NZ^F=A^-"SS.ZKI]F _K!E?5WE6S]L#5-^W]]-J!
MSZ_M33(E9*:C@-0%IB;:>AZ^X99]GZK;^ZE;!CZ][NY/WK27.GW_ZOH!;'(.
MV;>J?O#J^OZKU@Y>M>[NJVO[MG3]JV8B*YXE3%W )X_!AW^D.Q%\_ ZFB"F5
MAQE]<19FV<CN0/8T?+SA.$#DA8C^K_:%D>;\TN:YRV[?>N\+HZYUH"/G".<J
MY4J@TP+*($)A=CM."^@VW.F(^*!D]7#>4C46&8@NNYG*LE#,&A?49'X!1A=O
M^-\FST3" 8]$PR!D>9GIDQ0>A!_?A6;HH6&Z4[G%OR1$^[ZO7W[#^G,^&#[W
MPY59%Y6F%ZN^DK!_:=2WM#)M207(,B5196F%4AQ5%H>5DBC>+ ZG+0ZE+XGX
M%P>S+RJ=<U'IN9<$K[S^UGL>^/>X$*,F'%*LH[CMQP8AOS>CIY&IOGD. !D/
MR@"185"&5@=>^WF98*(>QP:P(41&D$,<+YV(ML^]+/9\^^7/M7__?]PP6!1N
MRE(W9P2VYH1WY$7;,M467]E6?V!;AMJ:7KX]*]J94]'C#[;[@YVYE7W9E;V(
M*HIPIC2 ,I27%VEZE4A/>@52]J+2?*33%^T&LR;8BEQ.P59_8$=.I#TKU)H7
M;<LHVYP7W#(GM*4PN'E!I&E!<./<%6O_6V1#Z,L'-AQ\\2M/)OZ8%,..&-'%
M*->G=82N,T.-.<F$J_+*2&WOC5H/A&*I\G 9.L&3MUE01DJL;9N@>I)Z(8M'
M."*9%+H]B?4E3A+U:HPN(\>V[>@VK@+Q.XJ1,:O 3/5T,8'KDU''JQG.=E7,
M42V&C OXD[&1;UHR\_W$]0W-$:"98N]P46'30KY(-YR-U5D>H!Y4-X%['G>*
M;1MQ2J65T(VX8<)Z3B11UMOB>=&"8\U!CBE0034+)9"Y8(KN",O"IMO25?/&
M*-V;I0DSQECWN)^:?3'-+>#:L:R(.\ A-&1IM6T]88/*1$'F%L%R,8JP2)*B
MABI*Q]$)(;WVV!:C)-9O)B'KND4EU6TRW.7TQ=XX5*#&PD&#9>)MX%G(7*M%
M0GRXD&V9NB/$<$*2<]A3&!/2:XBGL.6&Z#^+4@1;> >Y@BF,Q-89F#D#E[")
M]P!-:%**,,-PLA7&95#$VDPB'0&Y(4>H\3%ET7K%>XV.N2]2.X7?B9/(O6&+
MUQ/00P!EZR1)E-C.!65@!V+V<X5Y,G<_N7-3Y V%'Y!5>@QAA-FBF6(H =T>
M@\7"RNX])C^=3@*FD^P-&5(:WTR0Y!M"Q!$_,H/_'"$T75@B$1,) Z0XCZTO
M.]J=/62S.&B!(<I:A?!&JF6?M(#,:,*@O-W4&#2B@<0Q/7@&-]#I=>NDJY/$
MN6/'&[^H<T(JI:YC.OS=FZ*TIFUAV?KS [<U#OQHF$HGTI=(U^ .(J8,F43P
M9//%I^*!E?'VV9CW?/9];GB3';8H52,M#NIDMEE9:Z,B"V#'T'H/ZX'^J-,\
ML:"#\3D1IJY7IT)2CGU-#Y3AIJ!)G!8R7E$T(=Y(8N8:$N+QG[UR>]O^:,W:
M#T4_<_:'HKF+2G,7E8)$<_&*S(N695ZX/'])H'!I,'=1:5YQV<)_J/KOU3=<
M<<.=7UC?=L_]CP];8L0$'#-*FCYQT- /I*E[SM)94.;8G93Z[GBA8W"!A=G5
M/\BRPFDI'!F;*T/+(8"!8"5MK"".2%@B9F/M&1;B#4<\],1?^^__^?JV;UWQ
MA=X/5MU^06G]^67K%JH-YX:WY"QKR%R^.3O8GA7L0@7!R.ZTT,[T2+<OVDU[
M!%K[(GWI$2JUJ'8KX6ZJH-23%NI4PIW^BJZ<BIZ"8.?<\K8%H?:BTLWSRYOF
M+[_][R(-)2LW7+W^8'W7@W<_\N*3OXUSA/^P$,.<;I2\- 95TTV2^<4T*\E#
M9DN2VT6V!TLUJ4%NJ["P<?B,MZ<9(;5USX1C;J.W/BE2:!$WP+9M&[ UJ[!D
M"4UP-:'DZ&3*&\*),WAM05E!97)TBC3^J3.XQ]YZ'[/O3&L+4#<P@HG?Q4M(
M"!%]@=,9>ASIQ'4M*0"/HKK99#;'$<D$*_*V828H61O]BGQ(SBM$Z\X[$0BL
MR*83M\F)8$)1QAUB?J!8*9A*O-G0PJ2A3B1-6,@TL3CT48PRA5/\HV4YHT)H
M*2$ST]HALS\VU@(INCB!) 3*<%5I\K3QF99E)4UGQ*1^G[APDGLM2<L*"!2F
MAH#T5&8IQ!80'PG..P%EO*6)91#78R$G%Z!EF%BC'21#0@(X$_*9H 4.< L)
M,&=!0&",*0P#D"(YZD5<UPA@3)"-,=9@LT='MP WN%0,T/Y,EH$B0<<<N1G3
M=,!OY+MEUP'O,3$1((?"@9Q\RWV)^81)Y5Q=#LB9B;YT4Z6Y$ G $0G*3#VB
MP3]*,) [M?*S.YIMC!*O4&8J,&QAT.*,]9G*(G+92NB*-B1ME%!XABWB -??
M XG/D:/*,I,L PF*R8I1_)KA%H:$#N2@!5@ =%O$3;#+$2WHB*3&W:QI0'?0
M?K)+,5.QDG.T ,Z^/JD6D!,FKN%E[&9TVT*&!D0S60(FS(]_,?R1R^HO7/'E
MK8./Z^3N26CH:*"E\B*LV+CC@O3;D[JWXWQ9\0R,V8-CMH!LMY39T+%-TR"#
M =.GMU$8"(TQ3PR.=^#V,77V<3IFYKSM,652<!FB%]F.2.A0'V(<-D(KT!$J
M_A<7XJ\)\=1+?_[J=YZ^]\$GOOZ]YQ[XP0OW/?RCN_[U^]_X[G,OO3PZ1+['
M."4C2! 00_HN1@BF+W0'KQ5>^V,F)(QFYK3<*;G35*$\U@VD?L['+*Y0[SS5
M1*[3<K8B(QR)69&:AGUQ-A:AUV+B9_]///SCUP8?_.6FP2>_U/KHM0W?5&^\
MYX+JEMQE"'J:']E:$-C@;AL+ AL+ IMXHZA^A,'GE]V15W9;@7K[@HK&"ZHW
M5]_\+]>N^T;MCL<W[WOAT*.O??=GSJ^&4#[CB ,*<8RL/D);;*R23D)8"<[N
M)"M/">!'(XXS+K;  YOPC":J*HP5P&8!X^DX5=V"#*;,"L=JRO?F>]SWQW@V
MF])F02=Q+,NR@*+0NG7,>?68;R)P'<5:2=+8=8B^L.'J!:-;FA@LD&=J^Q^C
MY4_96]Q3+GJ+X2"G#_29 3<JE%7AR/+#"5)QCMGUQWF3*EJ2F\,T=0M!%S8[
M%-U'=C4D]B1/>D#:%MQ?L-4M^#XUY$03XDT#00JDC=GD:X&1RXHXQ\S20F.
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.@T4     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Feb. 23, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 23,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BioMarin Pharmaceutical Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-26727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0397820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">770 Lindaro Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Rafael<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">506-6700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMRN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001048477<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bmrn-20260223.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomarin.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="bmrn-20260223.htm">bmrn-20260223.htm</File>
    <File>bmrn-20260223.xsd</File>
    <File>bmrn-20260223_lab.xml</File>
    <File>bmrn-20260223_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bmrn-20260223.htm": {
   "nsprefix": "bmrn",
   "nsuri": "http://www.biomarin.com/20260223",
   "dts": {
    "inline": {
     "local": [
      "bmrn-20260223.htm"
     ]
    },
    "schema": {
     "local": [
      "bmrn-20260223.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "bmrn-20260223_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmrn-20260223_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.biomarin.com/role/DocumentandEntityInformationDocument",
     "longName": "0000001 - Document - Document and Entity Information Document",
     "shortName": "Document and Entity Information Document",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bmrn-20260223.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bmrn-20260223.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover page.",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.biomarin.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001048477-26-000002-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001048477-26-000002-xbrl.zip
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M&!=_\AI:<O79I=9///I$!0_)[9""YCV6*(A#.J&G%P^1;R2,>J&4<'0UH1
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M1UXQ$\KZ;FM"^]3_7().81D3 .S&ZP[2*<_)8!JPVB1?YOQ+HZ8;M>JVQU\
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M(-ND7[QW@=]>22 !(&EQX@TSVC:[R]>8]?!0Y1=->_EHB*$UB!R">K(9)R,
M>--]'O]1.;&A&^9<YE/'AG&#)4V)63B(=['*>IOPAY\+>(K*/>]Y.'JEL?65
M7]/1+6/;;82-VPMF?3<W?BV]47]Z\C<Z2[R/(X7@KRD]/O.RZ-=4$1A[P=(]
M2X/IJ<F]U-P/7227+/8$'^/C;:KMKSC=O)'M?O_E;*^K/C[%]AE=&ZY9:B"G
M7X8JDG[MC%% ;N$@SI"<9ME]YEI5-FGH0PE"1!!W5J:ON"VP/YV^QI375Y1O
M%<KM9B@W0W?9$D3!(W_#0N/-;_6^I5NOEX5I.'_)(+:>VW8$))!;!+(=W-T
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M#8;/=_=_\,2M8;<W%J,_4$L#!!0    ( !2!5UR?/NT<- H  'A5   5
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M2'2B: (Q"AD9"FJ7P)$!W4H&6\W B@ZGLK-/#M,XUJD;A8XFG=#;Y\0+N<Z
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M]S?O0[3Y;IR;J[>OMH]DZW_4^?;5_P!02P,$%     @ %(%77,F@,S2]!@
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MX^)[KSD+..#.,$<EE4J[K'@--Z9TWSVP7\GD7>O@89=Y,!@H$=[\.HNKV*
MGJCKCU/-]MOG&Z)IX$.EAFP2"0A!;<,L:+V"YKAL1),QV(-F%#AQ0,&A K-H
M'(&%3,XN;[Z<)[84>%R@HA7RY>]<)Z-S09GQ$P&^*'Y^@&H;7D&UZX<P%[@=
ML* 0S=V!2_GGG CU*FB]".T2-.2 SKD!!#;I,\ 1U M:$[ !"[4IZ"DP@L&V
M"< ) =?"; K**89R4F]L@'X/PCXQ)@'DJ2$1,N0G3LQE[^;VR[]2\RCK+)I@
MZ3VQ0Q5.)AIL*K8GB+OA9.S/H8_;R&R8RH8YW/MS;,<'<P-<*3 NT, #2HB
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M]M%5C<X)\Q;I-P)V:*(7NF3TR%;X#2,;*+N91P^$G7E@8S2,/YU&-)@_3[W
M!X\3R),?8#!ODP$AC3I.8P"X_$3P@!.=3#:-N6'LY_?I8<<R"1_2S.6G_R]R
M>@6'[<)A]TDDFL<ID#G0%LB$[V9QFD%,W87DH,%\0E'$3)CYH*D0A<4@:BEA
M9@'V*=2G9P3=*9JD-.;'(VJS2-80/DD #=] H8VI1Z-@%N]**<*TA_P(4&*'
M(/!^X/=A!J*J,SK(1E13@T8@OAC$IT[%(X9%F9N*^70IY!=.*%#AS!.&1.P
M;#L/,6=3.@:[?PW&,V=/B1A(#_<BO'F:>L7F@C?"185A9,/E_ MADWSF?R$8
M?'9X3!LG_-J\;Y*SVZ_WY[ Z'VQB%H'^[HQ@?V"AM4'$P,ATY^D>04$M[BWC
M&+.%,NZ83/WT). ?CR/S&TV7^NCZ_<P:CW^\NUH%_FFZ,68SC$9.Q._M"G8J
MPFN?'F:O/?^<RZ-#JDM/KA.B6WE*F<D307G;_T]RSI8Y9@$ST Q0..,90'+D
MDIX?@?5H?4O. S(K02[D9W#P+T"OR:;Q^0$QL"%;.? 9LQ=QM^E.4+0W$J$
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MBSM^S4<(<SD,88&'L"7J 5!Q<:WD*E\L-%ON;G="L]5:LPF]MJ->2Y-)5@9
M"U9Z1RYM4AT%1["NR0X5@O> R]*P=,YJ$:\%07[A6$LHZ\WNJZ%<%"@K *]=
MCJGV"ZRJ:VPC'WN73[WN365O*XZ"&D1?O,*J:)C#FL7P?^(P<@:3A01?C:>Z
M'O"F\OI*)_/NYRQ).DF=GV:H\WQWGA*?/=RJ!WS4<T(*KC8R&!2[ROU6&SGD
M:@]?;80A.5>UD;EB(QFS-5]]G0I1O+96(FR^16&&83Q:ND2ARK/2%?]@WZ%V
MHP>*#1DEG8<5!@[);1R%$0@3 %*N2YF% '7SQ<:C?FUYYEUF20T2>>$>PM$N
MH3\#&9 AWO4VV<5<&E"D&[!O7*9"GFG?,N$I"%K0OE8<XG7A.(B&Y*_8#+#H
M!4N G5W63B\51[YM3B3RV??8?S_0?H#7L3C1JIJ4W!LQ(Z+_](/1N=!D,FZ.
MFN3J 2] XR40K+X!"_'8%1#+ BF -T*&@1\_#KEH@'U]PTO$[(HQG=X>)B&U
M4NF O\\V2_O@6\)L$5_&\_-SL^_X(WS8M/S15@)?=XU$/<(UDFZ[V9:5%]TB
MZ32[<O$7,W:8MF;)L]N9CL$%[RO^](/>OK@T/=,V0=+":H L;V(LR,*X@'1D
MN=%6C$:WTRXFO;2X9+V20/&.(ONL!UY;;JBR-A_7/DUZNT9_U6,&'0CF50 C
M+;W5T.1V0^FVM"J1V]Z*.VRDN>T ;<G=!E)AMRMW5X0B]Q1?KC)\%0/@>SFS
M/*[?)Z2I&\#%LLPU]=[#NK4FWQ7@W0;=76K.'KA U)M?>WVLG9.:=0<J^[+Z
M-O;4M@1SU"1)*1N)/+I^'XUA+-\#!A]S7<'2C*@U]& ]CY-I9:2!#T8U925]
M;.HZ0#&L1!%62,*Z1<SA'5-_#)8E/'720IB/U*.,M,"=2TLY@OUN\R*<3?(!
M6W52O Y/E&ZW+:$AC#?'M>[%/9C4=^; I*Y$+H$PX0N>8S;P*,6>+FMHXGZP
MQ@_U\.:V]8T5  IL-*H=S_.?3'Z1FZUFA-68<(GP^H@&S!&(Y@IHF"0INF$!
M#''=[%<L$93^>^R,V5%.DWQEQ8%,!%SD>!:> 7$'UK2&S!$)XD?FC<#B@@F;
MR 9OP?7'6(1)FMG[(:7?6$&KV,/HP7!V9WQ6[PFVD\"2A);#>*0_(>,X"&-6
M<0*+0_C!I,&##G.H866-DF)+L+H!@CQ3;"DI+P+(>/"1,@*/C/R 2F3,0QE/
M6#F&;/=!1$V]]7ZLL2"ZJE!3[UA2<[%XWGT$M,W*EAU5@CXL!_G26BV9RAV;
M8A-8V,<$=E^L<A=.-TA,IC%PSFD]..#8<,SJSH (F(J,+T,S&)D6*][$J@E:
M37*6/CV7R+06C32MX>8Z(R=*I.'B)[FR36K*S8(D8QJP6#5L)S,E6U^F:!%;
MV?R5RWREE*7UM92SE3,:6#F#Q6'8^&25O/A;.*N8PV/!$_R2':"""GE@!6NO
M)-$>B=6)P^+!LRU0>UI8B56F2XLO/0;^,ZB,#-"GM7B62B]-2_E)\Q,G<[ R
M/$G&]FR]TU&S*B3SQR:\2A^OY#6KS87%9-(B,GW0" -GGC2FJP3" 7F9L_H7
M$A#_WO(\+G -0\BL@B#JZYEVS:*%;WFV] BH#H\W!H19IWRBC/J%5=JQE98D
MY-_"Z>;H*Z"/P# IZ<TIT=E4SG]GBYG_P#+_9(&$G\?XG>W8 .!PQ?ML@8L,
M,)N7(72Z35XY)N2E=)-Z@5/C(8Q@@N0;$<JD,+$O^"J8]? $O\X(%=^8$':.
MP($A)3^9]A/R)6-BB<#2L:"F:0,SL[?[(R<,^?B! Y]_1$Z93<]J/)I]ZB*@
M >8X<H:T*6E."8SQQY/IP#LP6S19"<P54)O;W@S(LP*4,PLG9;@Q<E.,&YX"
MBGKV$OS9D<&8PWH3P3"Y!/X/2FX6^$S+J8W]<>QRDCE[Z'WY<IX6^F1HG95
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M=$4N4G6XD[,,^WFG6V]??*3\$.33ITN L>LF489^@-3NF:/$:X:%/#D6#PZ
MNY?!Y2PRP<-$R3MC< 59:@$+SSF9P[: IG'W,<!MDKB)3I!&;/'XW7_VZ*:N
M/*=Z_MQ:?_Z,BW;LO[W9?L=#?U/>,^MCU5;FOO+U[><>& [DR^^]N\^]RZNO
M#]>7O4_D^N9R/2D>=<67MS?OKV[NK]X3^-O][:?K][T'^,?] _SG\]7-PSVY
M_8#+OYU)S7)MX&'://*!-X_\[+/FD5>KFT>RD? 7O9R[.;M&8>?',(4=3EO&
MV)B*'\PZ;<VZ=:[MMU6.W7SUS-AV(FJO7^!\=$N55UUA?<&%E;43'?C. ]@'
M>N=%=QZT9E=7"[_SH*A-N?VR:3<_TUHOZW%QE,6VNR]M9'&$Q1HO['2R=;'M
M(JZ^;+WCWBUGK9W5)?FY-LFJ$)0Y62U21"V>:H%D6:UNA,EKZ25'"7#YV'4/
M%B_!KN^T\9I*Y]EMG@:X]"*XJU80$03T"@)*1-&"S\]=[OT1URX@%]][Z?=R
MJIDC7';,1ZQW5W]>W7R]NF>Y:?NI:7@*0W<C U['6SLN/:PI9I=)> K6]"M:
ML2F9E(#"UY1]RK/\B\50W_'7W3&ZDJ8J"S<-U^\AI:L=]O("AA"X/\2ZVYHA
MM31=X/X$<:])2JLMM8VNP/X)8E^5.G)7TG5C[]BOC<ERES2PSZ:6;VFTJ*[<
MYDIR+@E=*(:DZF53"%6&IR*UVF43L16&IZ%)>E?09V'PU'5);R^6&2F%$M!*
MJ>_Y=>\=!'_N*&.9J:33UB6CM=E6V"6<>AR>K 4JVGI;TA1-H.+XJ& ]IB75
M$,@H 3+ H0';H*L<64A5/4Y_^^7JKO=P??.17/WS"V;*Y8[8%W4L5_0)W@E^
MLC8N]R46/O8'R?WG&KG9:MN0VK+P"XOSL[66I&@"H,79F4I;TG55 +2PR$5'
MEE1-Q%OSQUMI2,T JT'-%Y"LD1I0NJJD;W'F!)/M M"V)AE"KQ8'T"YXN%UM
M_P'"DP$HQF^4SOXCV+51 _?4=5FA(2P#'"2%B<U,E:@G6B.-H.LM297;@M\*
M\[1:+:DE %J@BI440Y-D18"T0)#*<E>25>$<Y ;9M1>9WJ.#EQO-,*017@V%
M)?%*EG72!U)';PE.*\R<E5I&V5)=*PQ.I2MI'4&>Q7&[)JG&_A5K;;3 1VPK
MX'OL?( 5I_2]61%_IA?JE)O'BKZJ%X+=!$ %0$\#H&>*#+Z!?%XN95#FU#Q_
MVG8%&R-XX>N2]"J3_M(%4TQIOS#YI>1I2)5!@M$QI*Z\V1X62-A_(IBB2&W!
M"\=&@];J2FUYL[>]7S14/1F/%Z(C9Y]N[^_/R8>[V\\DR<^[O;D_";5VINM2
M2UEK_P@NWG> IZ5(^I;3$X&$?4>%\*9FNR.0<%0D='1)53:?VQ]$FZ4?*[:\
MCQA:0"9U^7SB:RQ514/L6VGYHSHE2H"_JRHB+ZG S#FIU1'P+##/2^K*XJ)R
MD?#L=/:?*5L;@9]$/VLD\<]4J=WN[#,4?C+,!* TVFT!RH).:#K=KH!E(;!4
MI5:K59[3KO+)]UM6>(A;\^0L$?+G$O%HK>[%'"09\G3XJB5UVHH044540I&Z
M79'Y7&!\'P3^7FVZZ@C\/&= OUU]N+V[2CH4D8?>/Z]>=0Y4I0#LF=K&FP<[
M'P65/P9>)2PHK:[4VG+/7J#B0"<2JJ1O"=D)5!PF\4=7I';KR'6@JJ/I5@/Q
M2^ _.:'C>V3@3UV<R/Q>K_JJ74E719B]R/J5K:ZX@5)@'1U-,D3!VB(+ !_F
M(*@ZTG^UGW-S]4#F?)U7Y5A4L&)\SHV5D,3/]!;(C-T]LR,8H(48G16EHRJ0
MDJ*"M-0K55!5D%2Y24K3.Z" 7YB&+DA*D-0*IT-M29TMC7.$N[_%X+OJW=U<
MWWR\3T/;7Z[NR/WOO;LKB?S6N[^^W Y7#2!G^S'6 *F9 ;AQ9R5DB#.YJ>HY
M[+]-^SJ6:%U84ZT)J0JT)#=;N6]0;MF>("E!4LRK:'8V%S(6)"5(:K==J<TM
M"4K[)ZD:&X#OKS]]?;AZ_WK*$6Q1"4-02%E!3FMLP=PW+@5)"9+*9POF3ID1
M)"5(*I\MF#N\?/*VX&H0_H/]@]K$A*68CQ0V,1IA8<>A&="0^'$41J:'>Y!(
MWPP=:[>LUY=P3$F("UN$J$?W-8I,\ZLT,F2IU<E=B4,@8[_(4*1V)W=M&H&,
M?7.&K!X;&:>D!FW'C6%H?D7(M[,*]'4AP=R:L@A0'%M@U!^=+<GHY#*L!3JK
M@,ZVI'5S17,$.JN SI;4EG-9PL=$)S,(?HY,F!?^:SM/O_X"?Z0+')G!H^.E
M"U1DAEN^E3Z^E^QJ\;4$$+H!D!K[H8,M9]X%U&6]R"Z>'3L:)E#*OI5\19Z]
M8O9#'W7XVE<R>[4H%G;ANW<\&_[U3FM-U_M*E./.-^-<925XYB&2_1,7[=A_
M>^/(;5LV#-K7^W2@M]IJW]"T;KNM]_M*BQHM[7_;;])WAL&,O1YIHQ]0\UO#
M', VWYGNLSD)YX$Q DQE(9\#:(Q UJ-T";%+\"X&O-UMQV$,NK]=WW[NW5W?
MD"^_]^X^]RZOOCY<7_8^85)\<RTI'G7%E[<W[[%%_'L"?[N__73]OO< __BM
M]ZEW<WE%[G^_NGJX+^?2WU.+COHTX/)+4R2BRJK!6@O"7W12SE6?77LD&OHQ
M3&&'V._D:_.^"6+3=<T@E C];E&0DV,:<(<!>V+%7A2>EW0W7STSMAWP879;
M()/F"SK&0AB,0_HN_<N%[81CUYR\<SSV9?;2Q;S 1RFRH#W8]_CC1,!T.\V.
MP61,XE<F'T[$3Y,]6E!\_%E+:ZJ=[MK'<E-9^VS3M$JKJ>GK7]TT[>9GAMK:
MSV+U7-/F]-UWJ.2YPGI*U.C1<Q]2^4-2T;/6C3\5".AS$'AY(*<L^^O=WV>U
MWWI<Y4H4+[;4[>Z?K'I@[3(. B",I"?83S\8G26GI1B..TRAX1*W9+LTPR&S
MHRS\"_TK=IY,%T"_=(E_Q<XJ>')=]K-I1=(416J5[D:WP/XAUMW55:FC;\Y]
M/ORY2XFEU_W0#Z(&&! CXGA/-(Q&JT17A<L1J'@;4A,%2 H,A.I29TN6HF"Q
MK&%L62PJ00+P , X +^\;N5+NW)G:Z\0P60[ +35DB5#VW]%V-HPV34H+R_R
M@TF-N$J1U&[G($T 3H:O *2:*K6,LO55*#%G\0+<UEP\H4Y,UC&D=D>HKN(,
M;ED!U55*!E.-,C(8;^.\,X/U3>O;8P"6I=U(EC=@_[O(%>PL.Q5I4M?0)+V[
MY>K*JV%P[+29JF,)U:F>/PWVU"O#K ;CC>]9+XK7U_ HI<26T"??>ZQSJ$S'
M?.(#!$]/QA0R5/0W-N<,"E\C [ O@3^&-4PD,G9-E(:>S4[4QLAJM0N:&:ID
M;,DH%>RV6Q,E78/_;TZA%PPW%S:+3._1P?PR;GG4C<E419,ZFFA@5!Q #4-2
MM_1F%RR6 =A'W[>?'=>M$5/A70BE6[8,"P'0TV&J]W1 P6&VL5U*#6/2:!=*
M+=%WKTB0ZIVNI&VIM"EX;.G@IW;,I;;;X",(Y56@1:A(6K>43E>9#WQ6,]9^
M#W?*L?^U1;%>O^D2LD=;,KJZ)*M;"O)6Y"2KD-.KDI-AE:FM)74[':FK'[E+
M9O6O,WVZ[OUV_>GZX?KJGO1NWI/[A]O+O_]^^^G]U=W]3S]T5*5]0:[^^'K]
M\*_=SNDVW/O?VT%=WF]6_1PUO?3D.F;?<9W(H>+FTR$2F\?FA%U1QN,:T[*"
M&!SS# [$1:BCV!U&5Y*U_9OEXAI4^7#?DID=<&R7+"U)X/D>W4PNAQI9MP57
MS>FUEC7T7E(=*Y-!ET=*OW+[(L5QWZ*TQ.Y4.9@_D^#X MM\.YF+%,?"4QPM
MWV.K0;O>IOW:95\9W;:DM/=_''0RQP!&UY"4XR<[UL*$*Z=PX >"[E1$[&;$
M586.%4.6.HH0# 6V..](';64!0/*["KMVT6JDA&."3%M258WWRJLRAE:75TE
M1=(T6>H:E3U[*@?[WT>^]6WHNP"E,#UIPDL0T>2$KX7E1E.FEFHR10/'OU/T
M)DK[@QY');TL$)\2>2LW95DA8S,@3Z8;4X9,8LBR)//_ITTOS#@:^@%\QH8A
MW0N";1XT'-)5V D+=AYIMX#9]&[ZBA.&>.:"3^=:9L"S,;6P2K<[*XS!2T'7
MP*[HBJMJ1?86*J.!5DY'J <+Q8+V8*6-3<=N.!ZQS+$#5EN-_" #-#DV)!%,
M5B!(.[(JR:VC!TFJPVJ@0V'MDVE?*-2E9$A=F_0G)!I2<N-[?\6PNH$#"G!Z
M+0!?HUYH(I>2+Z[IU8@QSQ09[P>L:SHM.'(G6"J2JK;W"<O:L&+/LN)1[)K8
MKLWG1:& RP(Z!$8#"Y,X'OR;DC/7#\,E@%::1C1);VN"WXHX355$\;5=X'5'
M(Q-^M DU P^6')(S,\.&-ATXEA/5B=L40Y=4683?"Q1?75UJ=8V2Z;@RA][#
MM1&XW;IP5S>4VY+D3DOJ;KF2+.+J!W(;6T8;D%&IN'KIF3QSOL8"I_F9OA#:
M*@<H:GD'*N>-NW()+T%4Y2:J<EVL2[^7+I&?;!WCSMC1[JGMT.0VG24Y">RD
M3)/TE6W@+V]$(]R5Q,\Z5W:*:(2KR&]^?74GW+8Z7NZ$*QK>[FG%:QK>WC_
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M2P$"% ,4    "  4@5=<Y_V$::\/  "V80  $0              @ $
M8FUR;BTR,#(V,#(R,RYH=&U02P$"% ,4    "  4@5=<T3H(I'<"  !:!P
M$0              @ '>#P  8FUR;BTR,#(V,#(R,RYX<V102P$"% ,4
M"  4@5=<GS[M'#0*  !X50  %0              @ &$$@  8FUR;BTR,#(V
M,#(R,U]L86(N>&UL4$L! A0#%     @ %(%77,F@,S2]!@  .S$  !4
M         ( !ZQP  &)M<FXM,C R-C R,C-?<')E+GAM;%!+ 0(4 Q0    (
M !2!5UQ"6^#VRE,  'F1!0 >              "  =LC  !E87)N:6YG<W)E
J;&5A<V4M,C-F96(R-F5X.2YH=&U02P4&      4 !0!0 0  X7<

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>bmrn-20260223_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bmrn-20260223.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001048477</identifier>
        </entity>
        <period>
            <startDate>2026-02-23</startDate>
            <endDate>2026-02-23</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001048477</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2026-02-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">BioMarin Pharmaceutical Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-26727</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">68-0397820</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">770 Lindaro Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">San Rafael</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">94901</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">506-6700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">BMRN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
